Stockwinners Market Radar for August 13, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
NTLA | Hot Stocks20:22 EDT Cathie Wood's ARK Investment bought 119K shares of Intellia Therapeutics today
|
AUR | Hot Stocks20:21 EDT Cathie Wood's ARK Investment bought 564K shares of Aurora Innovation today
|
LUV | Hot Stocks20:12 EDT Elliott Management confirms to nominate ten new Board directors at Southwest - The company states: "Elliott Investment Management, which manages funds that together have an approximately 11% economic interest in Southwest Airlines, announced that it intends to nominate ten independent, highly qualified candidates to the Company's Board. Elliott plans to move forward expeditiously to formally nominate the Candidates. Elliott has previously called for three steps to put Southwest on the path to restoring its industry-leading position: 1) reconstituting the Board; 2) installing new leadership; and 3) conducting a comprehensive business review. Today's announcement represents a key step toward implementing the urgent changes needed at Southwest. The urgency of change is underscored by the substantial continued deterioration in Southwest's performance since Elliott initially published its materials on June 10 and the Board's actions in response to further entrench itself and resist change. When nominated, these Candidates would give shareholders a choice between the Company's existing Board, which has delivered poor returns for shareholders and has not held management accountable for Southwest's unacceptable performance, or a new Board that brings relevant expertise, fresh thinking and accountability. These Candidates were selected through a months-long global search for the best individuals with the optimal mix of backgrounds and expertise to address Southwest's current challenges and deliver on the Company's potential. The final group of Candidates includes four former airline CEOs and Deputy CEOs and six Candidates with complementary expertise in technology, hospitality, consumer-focused businesses, labor relations and regulatory oversight, including experience leading organizational change in these areas."
|
AAPL | Hot Stocks19:05 EDT Apple exec sells $1.12M in common stock - In a regulatory filing, Apple disclosed that its Principal Accounting Officer Chris Kondo sold 5.2K shares of common stock on August 9th in a total transaction size of $1.12M.
|
S | Hot Stocks18:57 EDT SentinelOne CEO Weingarten sells 60,864 class A shares - In a regulatory filing, SentinelOne president and CEO Tomer Weingarten disclosed the sale of 60,864 class A common shares of the company on August 12 at a price of $21.4687 per share.
|
ZTS | Hot Stocks18:44 EDT Zoetis CEO: The quarter and year have been driven by innovation - In an interview on CNBC's Mad Money, Kristin Peck said the company is working on products for diabetes and obesity.
|
FNV | Hot Stocks18:17 EDT Franco-Nevada to be at lower end of gold sales guidance range for 2024 - The company states: "We expect to be at the lower end of our 2024 Total GEO sales guidance range of 480,000 to 540,000 GEOs. Our Diversified assets are expected to contribute fewer GEOs than initially anticipated based on the revised commodity prices we assume for the remainder of the year ($2,300/oz Au, $27.50/oz Ag, $950/oz Pt, $900/oz Pd, $110/tonne Fe 62% CFR China, $75/bbl WTI oil and $2.25/mcf Henry Hub natural gas). With respect to our Precious Metal assets, we anticipate stronger deliveries in the later half of the year. Production at Candelaria is forecasted to be more heavily weighted to H2 2024, and we expect to benefit from the ramp-up of production at several new mines, including Tocantinzinho, Greenstone and Salares Norte."
|
FNV | Hot Stocks18:16 EDT Franco-Nevada reports Q2 sales of 110,264 gold equivalent ounces, down 35%
|
MTB | Hot Stocks17:28 EDT M&T Bank vice chairman Pearson sells 6,095 common shares - In a regulatory filing, M&T Bank vice chairman Kevin Pearson disclosed the sale of 6,095 common shares of the company on August 9 at a price of $162.275 per share.
|
ALL | Hot Stocks17:19 EDT Allstate sells American Heritage assets for $2B in cash - The company states: "On August 13, 2024, The Allstate Corporation, the "Registrant", entered into a definitive Share Purchase Agreement with StanCorp Financial Group, Inc., the Buyer, an Oregon corporation, under which the Buyer has agreed to acquire all of the shares of the capital stock of the Registrant's wholly owned indirect subsidiaries, American Heritage Life Insurance Company and American Heritage Service Company, comprising the Registrant's employer voluntary benefits business, for $2Bin cash, adjusted for the closing balance sheet. The Transaction is subject to regulatory approvals and other customary closing conditions."
|
XWEL | Hot Stocks17:02 EDT Xwell responds to CPC Pain & Wellness SPV`s decision - XWELL issued the following statement in response to CPC Pain & Wellness SPV, LLC's decision to withdraw its threatened proxy fight and related lawsuit against XWELL, in connection with the Company's 2024 annual meeting of stockholders. Bruce Bernstein, Chairman of the Board stated, "We are pleased that CPC decided to withdraw its threatened proxy fight and lawsuit against XWELL related to our 2024 Annual Meeting. Looking ahead, we are fully focused on delivering on our strategic plan to drive durable, long-term value creation for stockholders. We are appreciative of the constructive engagement we've had with stockholders to-date and look forward to continued engagement with them leading up to XWELL's 2024 Annual Meeting."
|
DUOT | Hot Stocks16:52 EDT Duos Technologies Group CEO discusses recurring revenues and EDC business - Duos Technologies Group closed initial 5-Year support services and data sharing agreement with Class 1 railroad valued at $10.9 M . The agreement provides full data availability for 7 existing client portals. Additionally, we now have data available from an eighth portal from a Mexican railroad, which we plan to leverage all 8 portals for subscription marketing starting in Q3."The Company continues to focus on establishing the foundation for long-term, sustainable growth particularly in the area of new business development and market expansion, patent awards and building our subscription data offering," said Chuck Ferry, Duos CEO. "The agreement executed with one of our major Class 1 customers represented the culmination of almost 12 months of negotiation and gives us a platform to supply safety data to all North American rail customers for both freight and transit. While I continue to be dissatisfied with our short-term financial performance, I am encouraged by the growth in our recurring revenues and the fast start of our EDC business."
|
WTO | Hot Stocks16:51 EDT UTime regains compliance with Nasdaq - UTime announced that it received a formal notification from Nasdaq that the company has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires the company's ordinary shares to maintain a minimum bid price of $1.00 per share.
|
MGRX | Hot Stocks16:50 EDT Mangoceuticals receives patent in India, initiates clinical trials - Mangoceuticals announced that it has received a Certificate of Grant and recordal of patent under section 43 of the Patents Act in respect of patent application no. 202117034253 with the Government of India, originally applied for by Intramont Technologies. The duration of the patent granted in India is 20 years from the effective filing date of the application, or until March 16, 2040. In parallel with this patent grant, MangoRx and Intramont have initiated clinical trials for this technology, collaborating with Vipragen Biosciences in India. These trials aim to demonstrate the efficacy of the formulation in preventing respiratory illnesses, with results expected later this quarter. The study focuses on evaluating the technology's prophylactic performance against select viral strains, including H1N1, with the potential to expand into further trials involving the H5N1 strain to address concerns related to avian influenza outbreaks.
|
FLUT DKNG | Hot Stocks16:48 EDT Flutter says Illinois taxes will be mitigated through optimized spend - Flutter Entertainment (FLUT) said in its earnings release, "During Q2, the Illinois Gaming Board announced an increase in gaming taxes which became effective from July 1, 2024. We expect to directly mitigate 50% of the cost in 2025 through locally optimized promotional and marketing spend. This is prior to second order mitigation impacts such as in-state market share gains, which we have typically observed market leaders such as FanDuel to benefit from over time when regulatory changes are introduced." Shares of DraftKings (DKNG), which plans on charging Illinois customers a surcharge, are down 5% to $29.78 following Flutter's report.
|
IBTA CART | Hot Stocks16:47 EDT Ibotta, Instacart announce strategic partnership - Ibotta (IBTA) and Instacart (CART) announced a strategic partnership to provide Instacart customers with access to Ibotta's catalog of digital coupons. By joining the Ibotta Performance Network, Instacart will deliver more coupons that are timely and relevant to its consumers. Going forward, Ibotta will be Instacart's preferred third-party coupon provider across all eligible categories of items on its mobile app and website. Ibotta-provided offers will be live across Instacart's platform later this year.
|
CTSO | Hot Stocks16:41 EDT CytoSorbents appoints Peter Mariani as Chief Financial Officer - CytoSorbents announces the appointment of Peter J. Mariani as Chief Financial Officer CFO , effective August 1. Mr. Mariani will report to Dr. Phillip Chan, Chief Executive Officer of CytoSorbents. Concurrently, Kathleen P. Bloch, CytoSorbents' current CFO, announced her retirement from the Company effective as of the close of business today, and will continue to serve in an advisory role as a consultant to enable an effective transition.
|
GOOGL GOOG | Hot Stocks16:40 EDT Alphabet falls 1% to $161.86 after report says DOJ may ask for breakup
|
LL | Hot Stocks16:39 EDT LL Flooring gets NYSE notice of delisting - LL Flooring announced that the Company was informed on August 12, 2024 by the New York Stock Exchange that based on the Company's and certain of its direct and indirect subsidiaries' voluntary petitions for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware, the staff of NYSE Regulation determined that the Company is no longer suitable for listing pursuant to the NYSE Listed Company Manual Section 802.01D, and accordingly, determined to commence proceedings to delist the common stock of the Company from the NYSE and suspend trading in the Company's common stock immediately. The Company's common stock is expected to continue trading on the OTC market under the symbol "LLFLQ."
|
USFD | Hot Stocks16:32 EDT US Foods announces $211M repurchase of shares from Sachem Head - US Foods announced that it entered into a Purchase Agreement to repurchase approximately $211 million of the Company's common shares beneficially owned by a fund managed by Sachem Head Capital Management LP , at a purchase price of $52.28 per share and inclusive of approximately $2 million of excise taxes. The purchase of the shares is a part of the Company's $1 billion share repurchase program authorized on June 1, 2024. The Company has approximately $691 million in remaining funds authorized.
|
KTCC | Hot Stocks16:32 EDT Key Tronic says most unfulfilled orders recoverable in FY25 - The company said, "As previously disclosed, a cybersecurity incident caused disruptions and limited access to portions of the Company's business applications supporting operations and corporate functions at its Mexico and U.S. sites during the fourth quarter of fiscal 2024. During the disruption of business, Key Tronic continued to pay wages in accordance with statutory requirements. The Company also deployed new IT-related infrastructure and engaged cyber security experts to remediate the incident. As a result, the Company incurred additional expenses of approximately $2.3 million and was unable to fulfill approximately $15 million of revenue during the fourth quarter of fiscal year 2024. Most of these orders are recoverable and are expected to be fulfilled in fiscal year 2025.Partially offsetting these additional cybersecurity-related expenses was a favorable weakening of the Mexican Peso that began in the latter half of the fourth quarter, decreasing expenses by approximately $0.6 million during the fourth quarter for fiscal year 2024, as well as an insurance gain in the amount of approximately $0.7 million, related to losses incurred from storm damage to the Company's Arkansas facility in 2022."
|
FLUT | Hot Stocks16:31 EDT Flutter Entertainment jumps 10% to $209.60 after Q2 report
|
BHIL | Hot Stocks16:31 EDT Benson Hill transfers listing to Nasdaq - Benson Hill announced that it will transfer its stock exchange listing to The Nasdaq Stock Market LLCfrom the New York Stock Exchange, effective Aug. 23, 2024, after market close. The Company expects to begin trading as a Nasdaq-listed company on Aug. 26, 2024, and its common stock will continue to trade under the symbol "BHIL."
|
DKNG FLUT | Hot Stocks16:31 EDT DraftKings falls 6% to $29.50 after Flutter results, comments on surcharge
|
EAF | Hot Stocks16:30 EDT GrafTech names Rory O'Donnell as new CFO - GrafTech announced that the Company's Board of Directors has appointed Rory O'Donnell to the position of Chief Financial Officer and Senior Vice President of the Company, effective September 3, 2024. Mr. O'Donnell will serve as a member of the Company's executive leadership team and report directly to Chief Executive Officer and President Timothy Flanagan. He will be responsible for overseeing all financial aspects of the Company.
|
GRAL | Hot Stocks16:30 EDT Grail Inc trading resumes
|
NDAQ | Hot Stocks16:26 EDT Nasdaq exec Peterson sells 40,000 common shares - In a regulatory filing, Nasdaq executive vice president Bradley Peterson disclosed the sale of 40,000 common shares of the company on August 9 at a price of $67.79 per share.
|
FIX | Hot Stocks16:18 EDT Comfort Systems USA increases stock repurchase program by 411K shares - Comfort Systems announced that its Board of Directors has approved an amendment to the Company's stock repurchase program to increase the shares authorized and remaining as available to purchase back up to 1,000,000 shares by authorizing the Company to acquire up to 411,426 additional shares of its outstanding common stock. The Company's existing stock repurchase program had previously authorized the repurchase of up to 10,944,125 shares of the Company's outstanding common stock.
|
GRAL | Hot Stocks16:00 EDT Grail Inc trading halted, news pending
|
NURO | Hot Stocks14:50 EDT NeuroMetrix says opportunities reviewed not in best interest at this time - NeuroMetrix said that "for the purpose of clarity," it reiterated that the company is engaged in a review of strategic alternatives. In February of this year, the company announced that it had initiated a review of strategic options with an objective of enhancing shareholder value. Over the past six months, NeuroMetrix "has invested considerable effort in evaluating a number of specific strategic directions and also making financial, operational and commercial optimizations." In collaboration with a financial advisor, the company conducted a "survey of potential transactions." However, the company determined that none of these opportunities were in the best interests of its shareholders at this time. The company noted that it implemented a reduction-in-force at the end of Q1 to lower operating expenses by over $500,000 per quarter. The company said it is engaged in discussions to sell certain international assets that are not central to its core domestic focus. "The Company believes it is in the best interests of shareholders that the strategic review process continues," it added.
|
ZK... | Hot Stocks14:24 EDT New Zeekr 5.5C EV batteries 'charge at fastest rate in the world' - Zeekr's (ZK) upgraded EV batteries support 5.5C ultra-fast charging that allows vehicles to charge from 10% to 80% in just 10.5 minutes, removing its customers' range anxiety. The new charging speed record is achieved by Zeekr's new 007 sedan model carrying the new lithium iron phosphate (LFP) batteries and connected with Zeekr V3 ultra-fast charging piles. Thanks to the optimized materials and upgraded technology, the speed is higher than what's achieved by existing nickel-cobalt-manganese batteries, representing the new achievement by Zeekr's in-house e-powertrain R&D team. Thanks to the enhanced battery management syste,m BMS, the vehicle's charging experience remains stable and fast even in harsh environmental conditions. At temperatures as low as -10 degree Celsius, the vehicles charge from 10% SOC to 80% SOC within just 30 minutes, assuring users of swift and reliable charging performance. Zeekr has opened over 500 ultra-fast charging stations in China with over 2,700 charging piles, all of which can support 800V charging. Zeekr plans to expand the network to 1,000 ultra-fast charging stations in 2024 and will be operating over 10,000 ultra-fast charging piles in 2026. Other publicly traded companies in the space include: Tesla (TSLA), General Motors (GM), Nio (NIO), Lucid Group (LCID), Li Auto (LI), Rivian Automotive (RIVN), Nio (NIO), Li Auto(LI) and Xpeng (XPNG). Reference Link
|
TLRY TAP | Hot Stocks14:17 EDT Tilray acquires four craft breweries from Molson Coors - Tilray Brands (TLRY) announced that the company has entered into a definitive agreement to acquire four craft breweries from Molson Coors Beverage (TAP). The acquisition includes Hop Valley Brewing Company, Terrapin Beer Co., Revolver Brewing, and Atwater Brewery. "Tilray's beverage business is poised for even greater success with the latest addition of sought-after craft beer brands, known for their unique portfolio of beers. With the pending acquisition of these breweries, Tilray's portfolio will expand across key beer markets adding 30% new beer buying accounts," the company said in a statement. Terms of the deal were not disclosed. Irwin Simon, Chief Executive Officer, Tilray Brands, added, "We are confident in our ability to drive revenue, generate cost synergies, and expand national distribution reinforcing our leadership position in craft beer resulting in tremendous growth opportunities for our global beverage business. Tilray Brands plans to continue to invest in the future of these craft breweries, accelerating their growth and capturing a wide range of new market opportunities."
|
TRMB | Hot Stocks14:11 EDT Trimble says EY work into material weaknesses to be completed in month - Trimble said the previously disclosed assessment by Ernst & Young is nearing completion, and the company plans to file its amended annual report "as soon as practicable once EY's work is complete." EY "has been performing and continues to perform incremental audit procedures responsive to the identified material weaknesses, and the Company currently expects EY's assessments of the impact of the matters noted above to be completed in approximately a month or so," Trimble announced in a regulatory filing. Based on the work to date, management has not identified any errors that would result in a restatement to the consolidated financial statements for the periods presented in the annual report or for any previously released financial results. Furthermore, EY has not withdrawn its audit report on the financial statements, the company added.
|
GOOG GOOGL | Hot Stocks13:58 EDT Google unveils Pixel Buds Pro 2 - Alphabet's Google announced the Pixel Buds Pro 2, the newest earbuds from Google Pixel. Pixel Buds Pro 2 are equipped with Google's all-new custom-designed Tensor A1 chip to power industry-leading audio performance, helpful Google AI, and improved noise cancellation, the company said. "Pixel Buds Pro 2 are 24% lighter and 27% smaller than Pixel Buds Pro," Google added. "After analyzing 45 million ear scans and conducting real-life wear tests, we designed Pixel Buds Pro 2 to be the most comfortable and secure fitting earbuds. Thanks to the new twist-to-adjust stabilizer, your earbuds stay put while still offering maximum personalized comfort. And they come with four different sized eartips, so you'll be able to find the perfect fit." Customers can pre-order Pixel Buds Pro 2 today for $229, and they'll be on shelves at the Google Store and retail partners on September 26. Reference Link
|
GOOG GOOGL | Hot Stocks13:57 EDT Google announces Pixel 9 Pro Fold - Alphabet's Google announced the Pixel 9 Pro Fold, which brings the company's biggest ever display on a phone into an even thinner foldable device. "Pixel 9 Pro Fold combines the best of Google hardware and software with a sleek and sophisticated design, an advanced camera system, multiple screens to get more done, and our most powerful Tensor G4 processor to fuel the Pixel features you know and love," the company said. "Google Pixel 9 Pro Fold is now available for pre-order now, and will be on shelves September 4."
|
GOOG GOOGL | Hot Stocks13:55 EDT Google unveils Pixel Watch 3 - Alphabet's Google announced the Pixel Watch 3, the "biggest leap forward for our flagship smartwatch, offering a stunning design combined with better-than-ever performance." The watch now comes in two sizes, including an all-new 45mm option, with comprehensive tools for fitness and recovery, plus on-the-go assistance with the company's deepest integration with Google and Pixel yet. Pixel Watch 3 also introduces a breakthrough feature with Loss of Pulse Detection that can potentially save lives, the company said. Starting today, customers can pre-order Pixel Watch 3 41mm at $349.99 for Bluetooth/Wi-Fi, $449.99 for LTE. The new 45mm is available for $399.99 for Bluetooth/Wi-Fi, $499.99 for LTE, at the Google Store, Google Fitbit.com and select retailers worldwide on September 10, 2024. Reference Link
|
GOOG GOOGL | Hot Stocks13:54 EDT Google announces new lineup of Pixel 9 phones - Alphabet's Google announced its new lineup of Pixel 9 phones, including the Pixel 9, Pixel 9 Pro, and Pixel 9 Pro Xl. Along with Pixel 9 Pro Fold, they are all powered by thte company's brand new Google Tensor G4 chip to bring you the very best of Pixel. "The Pixel 9 phones have an elevated new look that puts the camera front and center with an evolution of our iconic camera ba," Google said. "The sculpted design is stunning - and also feels good in your hand. They also feature updated finishes, with a silky matte glass back and polished metal sides for a distinctly premium feel. Plus, the phones are twice as durable as Pixel 8... Pixel 9 is packed with upgrades. With its 6.3-inch Actua display, Pixel 9 is 35% brighter than Pixel 8 and has been rated the best display in its class. As for the camera, you're getting the same main and ultrawide cameras as Pixel 9 Pro and Pixel 9 Pro XL. That's a huge upgrade for the ultrawide lens, from 12MP on Pixel 8 to 48MP on Pixel 9. And the front camera now has autofocus for even sharper selfies. Plus, the Pixel 9 has approximately 20% longer battery life during active use with the screen on when compared to Pixel 8." The company added that Pixel 9 phones are powered by its new custom silicon known as Tensor G4. Tensor G4 was designed with Google DeepMind and is optimized to run Google's most advanced AI models. It will be the first processor to run Gemini Nano with Multimodality. Pixel 9, Pixel 9 Pro, and Pixel 9 Pro XL are all available for pre-order today starting at $799, $999, and $1099. Pixel 9 and Pixel 9 Pro XL will be on shelves at the Google Store and retail partners on August 22. Pixel 9 Pro will be on shelves on September 4 in the U.S., along with Pixel 9 Pro Fold, with other markets on-shelf in the following weeks.
|
GAMC | Hot Stocks13:28 EDT Golden Arrow Merger Corp trading resumes
|
GAMC | Hot Stocks13:23 EDT Golden Arrow Merger Corp trading halted, volatility trading pause
|
HMC | Hot Stocks12:49 EDT Honda invests $21.5M to move ATV production to North Carolina - Honda North Carolina Manufacturing celebrated 40 years of production in the Tar Heel State with a ribbon cutting for new weld and paint operations for all-terrain vehicles. These improvements are part of a $21.5M investment that will complete the establishment of NCM as the exclusive manufacturing facility for Honda ATVs in North America. Honda also announced that NCM would become the first Honda production facility in the North American region to manufacture future electrified Honda powersports and power equipment products. "Our decision to make North Carolina the home for Honda ATVs today and our electrified powersports and power equipment products of tomorrow is based on the 40-year commitment of Honda associates in the Tar Heel State to build quality Honda products for our customers," said Mark Kohls, vice president of Honda Powersports and Products, American Honda Motor Co., Inc. Reference Link
|
CMG | Hot Stocks12:01 EDT Chipotle falls -10.0% - Chipotle is down -10.0%, or -$5.59 to $50.27.
|
KGS | Hot Stocks12:01 EDT Kodiak Gas Services falls -10.4% - Kodiak Gas Services is down -10.4%, or -$3.05 to $26.26.
|
TME | Hot Stocks12:01 EDT Tencent Music falls -15.5% - Tencent Music is down -15.5%, or -$2.04 to $11.09.
|
HUYA | Hot Stocks12:01 EDT Huya rises 14.8% - Huya is up 14.8%, or 66c to $5.12.
|
PACS | Hot Stocks12:00 EDT Pacs Group rises 15.5% - Pacs Group is up 15.5%, or $5.00 to $37.35.
|
LOAR | Hot Stocks12:00 EDT Loar Holdings rises 19.3% - Loar Holdings is up 19.3%, or $12.02 to $74.33.
|
ASTI | Hot Stocks11:46 EDT Ascent Solar announces 1-for-100 reverse stock split - Ascent Solar Technologies announced that effective before market open on August 15, 2024, it will complete a 1-for-100 reverse stock split of its common stock. At Ascent's 2024 Annual Stockholders Meeting on August 7, 2024, stockholders approved an amendment to the Company's Amended and Restated Certificate of Incorporation to affect a reverse stock split with the exact ratio to be set by its Board of Directors. The Board resolved to set the reverse stock split at the ratio of 1-for-100. Ascent filed an amendment to its Certificate of Incorporation with the Secretary of State in Delaware effective August 14, 2024, at 5:00 p.m. Eastern Time. As a result, every hundred issued shares of common stock will automatically be combined into one share of common stock. As explained in Ascent's Proxy Statement filed June 20, 2024, the Company believes that affecting the reverse stock split will assist in its efforts to meet the Nasdaq continued listing standards and to continue to have its common stock remain listed and traded on Nasdaq. In particular, Ascent expects the reverse stock split to increase the per share price and bid price of its common stock above the $1.00 required by Nasdaq's Minimum Bid Price Rule.
|
GMED | Hot Stocks11:41 EDT Globus Medical sinks after FDA posts warning letter for surgical robot - The FDA posted a warning letter sent to Globus Medical on July 15 regarding its Class II Excelsius GPS surgical robot and associated interbody spine and cranial modules. "This inspection revealed that these devices are adulterated," the FDA said in the letter. The FDA added that it is not clear Globus Medical's identified corrective actions will follow the requirements, including verification that corrective actions are effective. Shares of Globus Medical are down 9% to $66.74 following the letter being posted. Reference Link
|
GNS | Hot Stocks11:39 EDT Genius Group board approves dual listing on Frankfurt Stock Exchange - Genius Group's Board has approved the dual listing of the Company's shares on the Frankfurt Stock Exchange. Following an approach from interested parties seeking to provide European investors with access to trade Genius Group shares via the Frankfurt Stock Exchange, the largest stock exchange in Germany and the third largest in Europe, the Genius Group board has voted in favour of the dual listing, in which ordinary shares approved for trading by SEC and NYSE on NYSE American may be traded on the Frankfurt Stock Exchange. The Company expects trading to begin on the exchange within the next month, pending approval from the Frankfurt Stock Exchange, and will provide details once they have been confirmed.
|
ILMN | Hot Stocks11:02 EDT Illumina poised to accelerate revenue growth into high single digits over 3 yrs - Illumina is hosting a Strategy Update for investors to present its strategy and three-year financial outlook that features accelerating revenue growth and significant margin expansion. "Illumina built the foundation of the genomics industry, and we will continue leading innovation across total sequencing workflows to support the next phase of our customers' success," said Jacob Thaysen, CEO of Illumina. Illumina and the Broad Institute of MIT and Harvard are also announcing a new research partnership to advance single-cell sequencing and accelerate adoption of high-capacity single-cell experiments, leveraging Illumina's Fluent technology. As part of their work together, Illumina and the Broad will partner on the development and validation of new kits to catalyze large-scale PeturbSeq CRISPR screening. "Over the next three years, we will bring to market impressive new innovations that will redefine the genome and drive significant, deeper biological insights through multiomics." Illumina expects its strategy to enable the company to accelerate its revenue growth to high single digits by 2027. The company aims to drive double digit to teens non-GAAP diluted earnings per share growth from 2025 to 2027 by accelerating revenue growth, leveraging operational efficiencies, and allocating its significant free cash flow using a systematic and disciplined approach. "We have the right strategy to return to growth and increase our profitability. We are already executing that strategy and strengthening Illumina's relationship with customers in a challenging macroeconomic environment," said Ankur Dhingra, CFO of Illumina. "Looking ahead, we expect to see accelerating revenue growth over the next three years while also delivering differentiated earnings expansion."
|
WHLM | Hot Stocks10:59 EDT Wilhelmina trading resumes
|
GSUN | Hot Stocks10:52 EDT Golden Sun Health Technology Group Ltd trading resumes
|
MACA | Hot Stocks10:50 EDT Moringa Acquisition Corp trading resumes
|
WHLM | Hot Stocks10:49 EDT Wilhelmina trading halted, volatility trading pause
|
EXPGY | Hot Stocks10:47 EDT Experian acquires behavioral analytics firm NeuroID, terms not disclosed - Experian has acquired NeuroID, a leader in behavioral analytics. NeuroID's modern and frictionless capabilities amplify Experian's fraud risk suite by providing a new layer of insight into digital behavioral signals and analytics observed for both new and returning users throughout the customer lifecycle, including account openings, logins and transactions. NeuroID's behavioral analytics solutions are available now through CrossCore on the Experian Ascend Technology Platform as a key fraud-detection capability. Experian's identity verification and fraud prevention solutions helped clients avoid an estimated $15 billion in fraud losses globally last year. With NeuroID seamlessly integrated into Experian, clients can use one service provider to proactively monitor and analyze a user's real-time digital behavior/ The emergence of generative AI-driven fraud has motivated companies across industries from financial services to healthcare and e-commerce to seek new types of fraud-detection technology, such as behavioral analytics, within their originations and account management fraud strategies. Insights from behavioral analytics help mitigate fraud in real time and prevent identity theft, account takeover, bot attacks, next-generation bot attacks and fraud rings - empowering businesses to provide a seamless customer experience.
|
GSUN | Hot Stocks10:47 EDT Golden Sun Health Technology Group Ltd trading halted, volatility trading pause
|
MACA | Hot Stocks10:45 EDT Moringa Acquisition Corp trading halted, volatility trading pause
|
SBUX | Hot Stocks10:21 EDT Starbucks extends rally to 23%, shares up $94.61 after CEO change
|
HD | Hot Stocks10:12 EDT Home Depot says plans to delever over time before restarting repurchases - Home Depot says that will likely take the company into 2026.
|
HD | Hot Stocks10:01 EDT Home Depot says August comps better than July
|
PEN | Hot Stocks10:00 EDT Penumbra rises 12.2% - Penumbra is up 12.2%, or $20.63 to $189.42.
|
HUYA | Hot Stocks10:00 EDT Huya rises 14.1% - Huya is up 14.1%, or 63c to $5.09.
|
PACS | Hot Stocks10:00 EDT Pacs Group rises 16.3% - Pacs Group is up 16.3%, or $5.28 to $37.63.
|
KGS | Hot Stocks10:00 EDT Kodiak Gas Services falls -10.3% - Kodiak Gas Services is down -10.3%, or -$3.01 to $26.30.
|
TME | Hot Stocks10:00 EDT Tencent Music falls -12.4% - Tencent Music is down -12.4%, or -$1.63 to $11.50.
|
CMG | Hot Stocks10:00 EDT Chipotle falls -12.6% - Chipotle is down -12.6%, or -$7.05 to $48.82.
|
HD | Hot Stocks10:00 EDT Home Depot says consumer remains 'quite healthy' - Says consumer engaging in smaller projects. Says macro uncertainties causing customers to pause projects. Seeing further pressure in larger projects. Says does not feel the need to be more promotional at this time. Says managing expenses in an "exceptional way." Says SRS not reflected in comp sales guidance and won't be until owned for 12 months.
|
CMG | Hot Stocks09:48 EDT Chipotle falls -10.3% - Chipotle is down -10.3%, or -$5.78 to $50.09.
|
KGS | Hot Stocks09:48 EDT Kodiak Gas Services falls -11.7% - Kodiak Gas Services is down -11.7%, or -$3.42 to $25.89.
|
TME | Hot Stocks09:47 EDT Tencent Music falls -15.5% - Tencent Music is down -15.5%, or -$2.04 to $11.09.
|
GCTS | Hot Stocks09:47 EDT GCT Semiconductor rises 10.6% - GCT Semiconductor is up 10.6%, or 36c to $3.76.
|
HUYA | Hot Stocks09:47 EDT Huya rises 11.3% - Huya is up 11.3%, or 51c to $4.96.
|
PACS | Hot Stocks09:47 EDT Pacs Group rises 12.8% - Pacs Group is up 12.8%, or $4.15 to $36.50.
|
TOYO | Hot Stocks09:44 EDT TOYO Co Ltd trading resumes
|
SBUX | Hot Stocks09:43 EDT Elliott calls Niccol hire 'transformational step' for Starbucks - Elliott Investment Management released a statement from Elliott Managing Partner Jesse Cohn and Partner Marc Steinberg regarding Starbucks and its engagement with the company: "Elliott has become one of the largest investors in Starbucks because of our confidence in the long-term value-creation opportunity we see at one of the world's most important brands. Elliott has been engaged with Starbucks' Board over the past two months regarding our perspectives on the Company's key issues, and we view today's announcement as a transformational step forward for the Company. We welcome the appointment of Brian Niccol, and we look forward to continuing our engagement with the Board as it works toward the realization of Starbucks' full potential."
|
CRGX | Hot Stocks09:40 EDT CARGO Therapeutics Inc trading resumes
|
TOYO | Hot Stocks09:39 EDT TOYO Co Ltd trading halted, volatility trading pause
|
KSCP | Hot Stocks09:36 EDT Knightscope announces reseller issues 23-device purchase order - Knightscope announces that Knightscope Authorized Partner Transportation Solutions & Lighting, Inc., - Safety and Security Division - National Safety Systems issued a purchase order for 23 K1 Blue Light Emergency Phones to be installed at a leading Florida cancer center.
|
PWWBF | Hot Stocks09:36 EDT PowerBand Solutions signs two LOIs to become national lease partner - PowerBand Solutions has signed Letters of Intent with two separate companies naming PowerBand as their National Lease Partner. The first LOI is with a used vehicle company that has over 20 locations in 10 different states across the United States. The company has been in business since 2005 and carries more than 4,500 vehicles in inventory with a flooring capacity of over $100 million dealing in rebuilt vehicles. The company currently only offers retail financing through several National Banks and lending institutions. The second LOI is with a conversion van company that operates in 31 states with more than 90 locations providing services to disabled Veterans and citizens with disabilities. Through its national network, the company has the largest inventory of conversion vehicles in the U.S. along with other products, including wheelchair lifts and scooters, that improve mobility. Upon execution of definitive agreements with both companies PowerBand will be able to provide lender services for indirect financing to their respective customers by creating a competitive financing platform that incorporates PowerBand's proprietary lease calculation technology.
|
LWAY | Hot Stocks09:34 EDT Smolyansky family files consent statement to change Lifeway Foods leadership - Son and mother Edward and Ludmila Smolyansky, significant shareholders of Lifeway Foods announced the filing of a consent statement with the U.S. Securities and Exchange Commission, marking the launch of their "Life Back to Lifeway" campaign. The campaign seeks to replace the health food company's current Board of Directors, including CEO Julie Smolyansky, with leadership committed to revitalizing the company with a strategic vision aligned with the best interests of its shareholders. The Lifeway board has overseen significant and repeated failures of corporate governance that have harmed the business and its employees and driven poor financial results for shareholders. "Under my sister Julie's authority, Lifeway has been on autopilot for far too long, missing critical market opportunities due to a lack of strategic vision," said Edward Smolyansky, former COO of Lifeway Foods. "It's time for a fresh approach to leadership that prioritizes growth and innovation over personal agendas." Lifeway Foods Inc. was founded by Michael Smolyansky in 1986 and run with support from his wife Ludmila. When Michael passed away in 2002, his children Julie and Edward took over leadership, with Julie as CEO and Edward Smolyansky as COO. The Life Back to Lifeway campaign underscores the Smolyanskys' commitment to revitalizing the company with a clear vision and strategic plan that prioritizes greater marketing investments, improved ethical governance, and more efficient operations and processing techniques.
|
CRGX | Hot Stocks09:30 EDT CARGO Therapeutics Inc trading halted, volatility trading pause
|
DOUG | Hot Stocks09:29 EDT Bradley Tirpak urges Douglas Elliman shareholders to withhold vote on CEO - Bradley Tirpak announced he issued the a letter to the stockholders of Douglas Elliman, which read in part, " In my previous letter to stockholders of Douglas Elliman, I urged stockholders to "WITHOLD" VOTES ON PART-TIME CEO HOWARD LORBER at the upcoming Annual Meeting of Stockholders to be held August 21, 2024. I am pleased to report that Institutional Shareholder Services, a leading independent proxy advisory firm, agrees with me. They are recommending stockholders "WITHOLD" VOTES ON HOWARD LORBER. In addition, ISS recommends stockholders vote "FOR" PROPOSAL 4, the proposal to elect directors annually. ISS noted that "the ability to elect directors is the most important use of the shareholder franchise, and all directors should be accountable on an annual basis. A staggered board can entrench management and effectively preclude most takeover bids or proxy contests." I am also pleased to report that Glass Lewis, another leading independent proxy advisory firm agrees with me. Glass Lewis recommends stockholders VOTE "AGAINST" PROPOSAL 3, the advisory vote on executive compensation. As a reminder, in the recent proxy statement filed on July 11, 2024 with the Securities and Exchange Commission, stockholders learned that the compensation committee of the board of directors significantly lowered the metrics used to measure the success of the Company when awarding executive bonuses. Management was rewarded for losing money in 2023! A "WITHOLD" VOTE ON HOWARD LORBER, a vote "AGAINST" Proposal 3, and a vote "FOR" Proposal 4 will ensure that the board of directors understands that the compensation policies of the Company are flawed, and the Company requires truly independent oversight that aligns management compensation with stockholder returns."
|
LPLA | Hot Stocks09:27 EDT LPL Financial announces expanded suite of business solutions - At its annual Focus conference, LPL Financial LLC shared its priorities for helping financial advisors and financial institutions advance their businesses by providing personalized support that enables custom client experiences, building flexible operating environments by leveraging innovative technology, and supporting advisors' growth and legacy planning. In detailing the company's investments that serve to help LPL clients run thriving businesses, LPL announced today an expanded suite of business solutions, designed to help financial advisors and institutions more effectively manage and grow their wealth management practices. The suite, which has grown from three to 14 services over the past six years, is expected to reach 20 by year-end, and includes services co-designed with advisors to address common challenges.
|
VOXR... | Hot Stocks09:26 EDT Vox Royalty provides development update on Western Australia gold royalty assets - Vox Royalty (VOXR) is pleased to provide recent development and exploration updates from royalty operating partners, Northern Star Resources Limited (NESRF) and Evolution Mining Limited (CAHPF) public disclosures. Riaan Esterhuizen, Executive Vice President - Australia stated: "We are pleased to share positive updates at key Western Australian gold development royalties: Red Hill, Castle Hill and Kunanalling. Northern Star continues to reaffirm the strategic value and high quality of Red Hill within the context of the A$1.5B expansion of its KGCM operations, supporting Vox management's previous estimates from 6 May 2024 that the Red Hill royalty has the potential to generate approximately US$10 million in initial annual revenues. Similarly, Evolution Mining provided updates on the construction-stage Castle Hill project, which has been flagged as likely baseload ore feed for the A$250M Mungari mine life extension and mill expansion project, which is expected to be completed in Q1 2026. We look forward to sharing further updates from our respective operating partners in the coming months as projects are progressed closer toward mining or restart decisions, as applicable." Key Updates: Northern Star provided additional detailed disclosure on Red Hill's mineral resource estimate and status as a "strategic regional opportunity" for the KCGM operation. Evolution provided a construction update at Castle Hill and referenced a new gold deposit which is located on Vox's West Kundana royalty tenure.
|
HD | Hot Stocks09:24 EDT Home Depot sees FY24 CapEx ~2% of sales - Says capital allocation strategy remains unchanged. Expects consumer demand in 2H24 to be "consistent" with 1H24.
|
LQR | Hot Stocks09:24 EDT LQR House announces 382% year-over-year revenue growth in July - LQR House announced a significant 382% year-over-year increase in revenue for the month of July 2024 compared to the same period in 2023. The Company attributes this substantial growth to its strategic marketing partnerships and increased traffic to its online marketplace, CWSpirits.com. In July 2023, LQR House reported revenues of $46,450. In July 2024, the Company experienced a significant revenue surge, reaching $224,227.15. Sean Dollinger, CEO of LQR House, stated, "Our recent growth has been incredibly motivating for both me and our dedicated team. While we understand that some investors may struggle to see the value of an online marketplace as a tangible asset, we feel this growth clearly demonstrates its true potential. In addition to owning what I believe is the leading online alcohol store, we continue to secure new marketing contracts with top-performing brands, further enhancing our bottom line."
|
ALTS | Hot Stocks09:23 EDT ALT5 Sigma Corporation reports 114% y/y increase in July transaction volume - According to the company, ALT5's transaction volume exceeded $179 million for the month of July 2024, which represents a year-over-year increase of 114% from the $84 million recorded in July 2023. ALT5's year-to-date transaction volume is $1.05 billion, which represents a year-over-year increase of 101%."Based on historical seasonality that we have experienced over the last few years, the second half of the fiscal year traditionally sees an uptick in transaction volume. We are pleased with the year-over-year growth and encouraged by the month-over-month increase in business as well," said Vay Tham, Chief Revenue Officer of ALT5 Sigma Corporation. "We continue to focus on growth and providing our solutions to an expanding set of organizations in our core markets," further added Mr. Tham.
|
IE | Hot Stocks09:22 EDT Ivanhoe Electric secures 100% ownership of mineral rights at Santa Cruz Copper - Ivanhoe Electric, through its wholly-owned subsidiary Mesa Cobre Holding Corporation, completed the final $10 million payment to exercise its option to acquire 100% ownership of the mineral rights at the Santa Cruz Copper Project in Arizona. Following this transaction, Ivanhoe Electric now owns 100% of the mineral and surface rights for the Santa Cruz Copper Project. Taylor Melvin, Ivanhoe Electric's President and Chief Executive Officer, commented: "Completing our option agreement and securing 100% ownership of the mineral rights at our Santa Cruz Copper Project in Arizona is an important milestone for our Company. We have now completed the consolidation of surface and mineral rights ownership at one of the largest and highest grade undeveloped copper resources in the United States that is located entirely on private land."
|
CXDO | Hot Stocks09:21 EDT Crexendo surpasses 5M global users - Crexendo announced it has surpassed 5 million global users. Crexendo's software platform is the third largest, and fastest growing software platform in North America, according to Frost & Sullivan, and is growing at nearly twice the rate of the two largest platform providers in the UCaaS industry, thus firmly establishing Crexendo as a top-tier provider on a global stage.
|
WGO | Hot Stocks09:19 EDT Winnebago announces appointment of Chris West as President of Winnebago Brand - Winnebago Industries announced key changes to its executive leadership team to bolster its position as the trusted leader in the premium outdoor recreation market and drive its next phase of growth. After four years with the company, Winnebago brand President Huw Bower will step down from his role on August 31, 2024. Chris West, currently Senior Vice President of Winnebago Industries enterprise operations and Barletta Boats, has been named President of the Winnebago Outdoors businesses - Winnebago-brand motorhomes, Winnebago-brand towables, and Winnebago-brand specialty vehicles - effective September 1, 2024. In addition, Barletta Boats President, Jeff Haradine will join the Winnebago Industries executive leadership team and report directly to CEO Michael Happe, effective September 1, 2024.
|
ACHR | Hot Stocks09:19 EDT Archer's indicative order book increases to nearly $6B with FFG deal - Archer Aviation and Future Flight Global, FFG, announced an agreement focused on the deployment of electric vertical take off and landing aircraft eVTOL services across top global markets...The agreement includes the planned purchase by FFG of up to 116 of Archer's Archer's indicative order book increases to nearly $6B worth up to $580M. The two companies are now working to formalize definitive agreements covering the intended aircraft purchases and strategic operating alliance, with nearly $5M in pre-delivery payments planned upon their completion. .."This new agreement both grows our prospective order book to nearly $6B, and opens up Archer's global reach to premium international markets," said Andrew Cummins, Director of Business Development at Archer. "As our first private aviation partner, and with their deep ties in aviation and bold approach, FFG is positioned to be a new leader in modern aviation. Partnering with Karan and the team at FFG was an obvious choice and an ideal relationship for Archer."
|
IEHC | Hot Stocks09:19 EDT IEH Corp files form 10-Q for with SEC - IEH Corporation filed with the Securities and Exchange Commission its quarterly report on Form 10-Q for the fiscal quarter ending June 30, 2024. For the quarter ended June 30, 2024, IEH had revenues of $7,104,977 as compared to $4,679,845 for the quarter ended June 30, 2023 reflecting a 52% increase; an operating profit of $332,979 for 1st quarter fiscal year 2025 as compared to an operating loss of $1,334,392 for 1st quarter fiscal year 2024; a net profit of $392,787 for 1st quarter fiscal year 2025 as compared to a net loss of $1,315,902 for 1st quarter fiscal year 2024; and a basic earnings per share of $.17 for 1st quarter fiscal year 2025 as compared to a basic loss per share of $.56 for 1st quarter fiscal year 2024. Dave Offerman, President and CEO of IEH Corporation commented, "By every notable metric of financial performance, IEH has experienced significant growth and improvement in this quarter compared to the same quarter of last year. Revenue, gross margins and operating income all increased considerably, and after 2 years of losses due to jet groundings, COVID-induced contractions in the commercial aerospace supply chain, higher costs and shifting defense priorities, we achieved profitability. While this does not approach our pre-COVID top and bottom line results, it is nonetheless noteworthy when considering the difficulties of the last few years and the continued industry challenges. Growth and improvements may still be uneven from one quarter to the next while the commercial aircraft industry continues to produce below their target levels, but our long-term forecasts for that sector, along with strong growth projections in our defense-related business, bode well for IEH in the years ahead. On behalf of the management team and staff of IEH, we again wish to express our sincere gratitude for the support of our valued shareholders. We look forward to sharing more positive news in the coming months and quarters."
|
DSX | Hot Stocks09:17 EDT Diana Shipping announces time charter contract for m/v Astarte with Paralos - Diana Shipping announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Paralos Shipping Pte., for one of its Kamsarmax dry bulk vessels, the m/v Astarte. The gross charter rate is US$14,000 per day, minus a 5.00% commission paid to third parties, for a period until minimum July 15, 2025 up to maximum September 15, 2025. The charter is expected to commence on August 18, 2024.
|
SBUX | Hot Stocks09:17 EDT Starbucks extends rally to over $90 after CEO change, Baird upgrade - The shares are up $13.00, or 17$, to $90.03 in premarket trading.
|
ACON | Hot Stocks09:16 EDT Aclarion announces their third payer coverage of Nociscan by Vitality in London - Aclarion announced their third payer coverage of Nociscan by Vitality in London, UK in conjunction with The London Clinic, one of the UK's largest and most renowned independent hospitals. With the addition of coverage by Vitality, payer coverage for Nociscan is now available from three major private medical insurance groups in the UK, a global healthcare market with more than nine million residents.
|
HD | Hot Stocks09:16 EDT Home Depot says big ticket transactions down 5.8% in Q2 - Says Pros outperformed DIY, but both were negative for the quarter.
|
HD | Hot Stocks09:16 EDT Home Depot says big ticket transactions down 5.8% in Q2 - Says Pros outperformed DIY, but both were negative for the quarter.
|
NRXS | Hot Stocks09:15 EDT Neuraxis announces BCBS of Vermont medical policy coverage for PENFS - NeurAxis announced medical policy coverage for Percutaneous Electrical Nerve Field Stimulation, PENFS, for Blue Cross Blue Shield, BCBS, of Vermont Medical Members, effective 10/1/2024. This medical policy will bring our national total coverage for PENFS to roughly 23 million, with more decisions from major payers still pending. "We are excited regarding the coverage expansion in the state of Vermont, home to the renowned University of Vermont Children's Hospital," said Brian Carrico, President and Chief Executive Officer of NeurAxis. "We continue to make progress on our commercialization strategy goals for IB-Stim by increasing payer coverage to drive market adoption of our technology. We are on track to achieve our stated goal of having medical policy coverage for at least 50 million lives by the end of 2024, which will set the stage for a significant revenue ramp in late 2024 and into 2025," Carrico concluded.
|
MKSI ROG | Hot Stocks09:13 EDT MKS Instruments appoints Mayampurathas EVP, CFO, treasurer - MKS Instruments (MKSI) announced that Ram Mayampurath has been appointed Executive Vice President, EVP, Chief Financial Officer, CFO,and Treasurer, effective October 14, 2024. He will report directly to John T.C. Lee, President and Chief Executive Officer, and will be a member of MKS' executive team. A global business leader with more than 25 years of experience in financial strategy, thought leadership, and value creation for shareholders and stakeholders, Mayampurath will join MKS from Rogers Corporation (ROG).
|
UAMY | Hot Stocks09:13 EDT US Antimony announces new critical minerals exploration play - United States Antimony announced the execution of a definitive agreement to acquire a 100% ownership interest in ninety-seven mining claims and three mining leases located in the Sudbury District of Ontario, Canada. The property covering approximately 1,741 hectares is located on Provincial lands in Ontario, Canada. Previous work on the property has concentrated on showings of high-grade cobalt, nickel, copper, bismuth with minor silver and gold values. Cobalt, nickel, and bismuth are included on the USGS "Critical Minerals" list. The recently announced Canadian government billion-dollar plan to boost Canada's critical minerals sector is focused on six particular materials. Three of the six are cobalt, nickel, and copper. The property is accessible by a provincial highway and numerous logging roads. The mainline Canadian Pacific Railroad, with sidings and loadouts, is within a few miles of the claim boundary. The property is located within ten miles of the north rim of the Sudbury Basin, which is Canada's premier mining district, with several modern mining complexes which include open pit and underground mines, flotation mills, smelters, and refineries. Some of these operations have shown continuous production dating back to the late 1880's. Other companies in the area of interest include North America's largest producer of nickel and cobalt as well as Canada's largest copper producer. Our new leases are located in an area adjacent to significant existing infrastructure and ongoing activity from other companies in a community that understands the importance of mining.
|
HD | Hot Stocks09:11 EDT Home Depot says 'continued uncertainty' around consumer demand - Says fundamentals of home improvement market remain strong. Says continues to gain market share. Says making progress on order management system. Says store readiness, execution "strong." Comments taken from Q2 earnings conference call.
|
DASH WBD | Hot Stocks09:11 EDT DoorDash teams with Max to introducestreaming benefit for 'Pass members' - DoorDash announced a partnership with Max, Warner Bros. Discovery's streaming service that brings together exclusive original series, blockbuster movies and documentaries as well as a library of beloved TV from leading brands like HBO, Warner Bros., A24, Adult Swim, ID and the DC Universe. Starting today, Max With Ads is now included with a DashPass Annual Plan membership in the U.S. at no additional cost, giving consumers a $240 annual value for $96/year.* Max is the first streaming service included with DashPass, the membership program that offers the most affordable way to order on DoorDash. DashPass offers exclusive deals, members-only benefits, and $0 delivery fees and reduced service fees on eligible orders from thousands of restaurants, grocery stores, and retailers. Additionally, for those seeking ad-free entertainment, DashPass Annual Plan members can upgrade to a Max Ad-Free subscription for a discounted rate of just $10.99/month ..
|
DKS | Hot Stocks09:10 EDT Dick's Sporting to build new distribution center in Fort Worth, Texas - Dick's Sporting Goods plans to construct an 800,000-square-foot regional distribution center in Fort Worth, Texas, which is expected to bring 300 new full-time jobs to the region over the next 10 years. The next generation facility will support Dick's business in Texas and provide distribution capabilities to more than 100 Dick's Sporting Goods stores across several states. Construction on the facility is scheduled to begin early this fall with a groundbreaking, and the building phase is expected to produce more than 800 temporary construction jobs to the area. The facility is expected to open in early 2026.
|
RCI | Hot Stocks09:10 EDT Rogers, SenseNet partner for wildfire detection technology - Rogers and SenseNet announced they will introduce wildfire detection to 10 communities as part of their commitment to keeping Canadians and first responders safe. SenseNet will bring the Vancouver-based company's AI technology to communities across the country, starting in Alberta and British Columbia. Powered by Rogers 5G network, SenseNet's technology will integrate advanced gas sensors, smoke detection cameras, AI algorithms and real-time data analysis to provide accurate and early alerts for wildfires.
|
AIFF WAVD | Hot Stocks09:09 EDT Firefly Neuroscience CEO issues letter following closing of merger - Firefly Neuroscience (AIFF) issued a letter to its stockholders from its Chief Executive Officer, Jon Olsen, following the closing of its merger transaction with WaveDancer (WAVD). Olsen and David Johnson, Executive Chairman, encourage stockholders to view this video message and investor presentation regarding the global brain health problem today and Firefly's vision for the future. "This week's closing and the addition of working capital puts us in a position to execute on our strategic objectives... We plan to execute upon two key strategic pathways to support better outcomes. First, the commercialization of our FDA-cleared Brain Network Analytics technology to neurologists in the United States, and second, partnering with Central Nervous System drug companies to advance the development of new treatments for people with brain health disorders and illnesses.... Today our team is very well positioned to continue its commitment to improving patients' lives. Your trust and confidence in Firefly have helped us build the remarkable company we have become, and one whose future has never been brighter."
|
ISPO | Hot Stocks09:08 EDT Inspirato announces investment agreement with One Planet Group - Inspirato entered into a definitive investment agreement with One Planet Group on a comprehensive transaction that includes $10 million of equity financing in exchange for approximately 2.9 million new shares of Inspirato Class A Common Stock and an equivalent number of warrants. "I'm incredibly excited for what this transaction does for the future of Inspirato and our members," said President, David Kallery. "Over the last several quarters, we've worked tirelessly with our members top of mind to improve our product offerings and optimize our portfolio. While the decision to reduce our workforce was not easy, I'm grateful for the hard work and dedication of the entire team and am confident that under Payam Zamani's leadership, Inspirato will continue to provide a world-class travel experience to its members for years to come." Upon closing, One Planet Group will name three new Directors to the Inspirato Board of Directors, including Mr. Zamani as Chairman. The size of the Company's Board is expected to remain at seven Directors. The Company also plans to implement initiatives expected to reduce costs by approximately $25 million on an annualized basis. This includes a reduction in workforce of 15% and the termination of previously impaired, poorly performing leases. CEO and Chairman, Payam Zamani, commented, "This transaction, not only strengthens Inspirato's liquidity and improves the Company's capital structure with a large, supportive shareholder, but it injects our boardroom with a fresh perspective. I look forward to working with the team, meeting our members and taking Inspirato to new heights in a more sustainable and profitable manner." The purchase price for each share and warrant in the transaction is $3.43. The first tranche of the transaction will close August 13, 2024 for consideration of approximately $4.6 million; the second tranche is expected to close in September 2024, subject to shareholder approval, for consideration of approximately $5.4 million. Following the second closing, One Planet Group will have an option to invest an additional $2.5 million on the same terms.
|
ALK | Hot Stocks09:06 EDT Alaska Air invests in JetZero - Alaska Airlines announced an investment in JetZero, a company developing a new blended-wing body aircraft that will provide up to 50% less fuel burn and lower emissions. The investment, which includes options for future aircraft orders, was made through Alaska Star Ventures, the airline's investment arm whose purpose is to influence the future of the aviation industry. JetZero's BWB aircraft integrates the wings and fuselage into a single shape, reducing aerodynamic drag.
|
BIRD | Hot Stocks09:05 EDT Allbirds announces Tree Glider silhouette - Allbirds unveiled its newest silhouette: the Tree Glider, a go-anywhere, goes-with-anything shoe that is crafted to perfectly complement an active lifestyle. The company said, "Inspired by the feeling of lightness, the Tree Glider exudes effortless ease with soft lines and elevated curves, subtle knit detailing, and a lightweight construction. The distinct design blends aesthetic and athletic to transition seamlessly between settings. Its outsole traction pattern is designed for dynamic movements and made to move with you through your day - whether you're hitting your step count, or hitting up a new lunch spot with friends."
|
ADIL | Hot Stocks09:05 EDT Adial Pharmaceuticals signs agreement with Boudicca Dx - Adial Pharmaceuticals announced a collaboration with Boudicca Dx, a global precision medicine testing accelerator. Under the agreement, Boudicca will support Adial in advancing its technical and regulatory strategy for the Company's companion diagnostic genetic test, to ensure it is validated both technically and clinically per FDA guidelines as part of Adial's regulatory strategy for its lead investigational asset, AD04, a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder. Adial's companion diagnostic is intended to accompany AD04 in identifying potential patients, including recruitment for the Company's planned Phase 3 program.
|
TENB | Hot Stocks09:04 EDT Tenable names Shai Morag as Chief Product Officer - Tenable announced that it has named Shai Morag to the role of chief product officer. Morag will focus on delivering increased momentum and scale across Tenable's entire portfolio, driving the company's next era of growth by building security products for a cloud-first world. Morag joined Tenable in 2023.
|
LIQT | Hot Stocks09:04 EDT LiqTech obtains NSF certification for pool system solution in U.S. - LiqTech received NSF certification for its Aqua Solution swimming pool water filtration systems. This certification makes it possible for LiqTech to market and sell its swimming pool water filtration systems in the U.S. The Aqua Solution is a LiqTech ceramic filter solution for liquids with suspended solids.
|
AVGO | Hot Stocks09:04 EDT Broadcom introduces Catalyst initiative - Broadcom announced Catalyst, an extension of Broadcom's Accelerate Program and a revolutionary global initiative that enlists elite Enterprise Security Group partners to lead the go-to-market and customer relationships for the Symantec and Carbon Black portfolios, with certain sole distribution relationships by region. Inaugural Catalyst Partners include TD SYNNEX, Arrow Electronics, MBCOM Technologies, Westcon-Comstor, and Carahsoft Technology Corp. Backed by Broadcom's product innovation and enablement tools, Catalyst unlocks each partner's potential to drive significant profit growth while empowering elite, in-country technical experts to deliver value-added services and Tier 1 and Tier 2 support to the customers of these iconic security brands.
|
SGPYY | Hot Stocks09:03 EDT Sage announces enhancements, updates for Sage Intacct - Sage announces new enhancements and updates for Sage Intacct customers globally, to streamline financial operations and enhance security worldwide. As part of this major expansion, Sage Intacct is rolling out AP Automation globally. In the US, businesses are already processing over 10,000 bills per month using this innovative tool, which utilizes AI to halve the time taken for accounts payable processes while saving organizations over $100,000 per year. AP Automation streamlines financial workflows by automatically creating draft bills from uploaded documents, promptly identifying issues such as duplicates, and significantly reducing data entry efforts and costs.
|
AXON | Hot Stocks09:02 EDT LVT integrates with Axon's real-time crime center platform - LVT announced it has entered a strategic partnership with Axon integrating with its Fusus by Axon real-time crime center technology. By combining intelligence from LVT's mobile, solar-powered security units with Fusus by Axon's advanced real-time operations platform, retailers, businesses, and law enforcement agencies can more effectively monitor potential safety threats and execute a response with optimal situational awareness.
|
GIC | Hot Stocks09:01 EDT Global Industrial introduces GlobalPure PFAS water filter - Global Industrial Company announced the launch of the newest product in its Made To Exceed line of Global Industrial Exclusive Brands: the GlobalPure high-capacity PFAS water filter. The new GlobalPure PFAS water filter is designed to improve drinking water quality. Featuring an advanced filtration system, it removes total PFAS and a full range of chlorine, lead, cyst, turbidity, and microplastics. Its 3,600-gallon capacity reduces filter replacement frequency to just once or twice per year, depending on usage, to deliver the lowest total cost per gallon versus comparable models.
|
APVO | Hot Stocks08:59 EDT Aptevo Therapeutics initiates Phase 1b/2 'RAINIER' AML trial - Aptevo Therapeutics announced initiation of the Company's Phase 1b/2 dose optimization trial, "RAINIER," as part of its ongoing program to evaluate APVO436 in combination with venetoclax + azacitidine for frontline patients with acute myeloid leukemia. RAINIER will be conducted in two parts. First, a Phase 1b frontline AML study followed by a Phase 2 study. The Company also announced that APVO436 has received its generic name, mipletamig and will refer to its lead candidate by this name moving forward. This frontline AML study is a multi-center, multi-cohort, open label dose finding study of up to 39 patients across five dose levels ranging from 9 mcg - 140 mcg in combination with venetoclax and azacitidine. Subjects will be adults aged 18 or older, newly diagnosed with AML who are not eligible for intensive induction chemotherapy. Phase 1b consists of 28-day cycles of treatment in five sequential cohorts. Aptevo has partnered with Prometrika, a premier contract research organization, for the RAINIER trial. Primary endpoints: Evaluate the safety, tolerability, and maximum tolerated dose of increasing doses of APVO436 in combination with venetoclax and azacitidine in patients with newly diagnosed AML; Determine the recommended Phase 2 dose; Assess incidence of cytokine release syndrome at each dose level. Secondary Endpoint: Determine the efficacy of increasing doses of APVO436 in combination with venetoclax and azacitidine in patients with newly diagnosed AML.
|
GAME | Hot Stocks08:58 EDT Zoned, 5-Hour ENERGY partner to host Fortnite competition - Zoned and 5-hour ENERGY partner to host Flavor Wars, a streamer community competition, to celebrate Fortnite's 230 million monthly active players and its cultural phenomenon status. This pinnacle move in mainstream gaming culture gives fans the opportunity to level up their skills and represent their favorite streamer to battle it out for a $10,000 cash prize and bragging rights as the ultimate gaming fanbase. Since gaming audiences prefer interactive and native ways of brand engagement over traditional ads, this new experience engages gamers in an innovative way that intersects one of the most popular digital game with the number one selling energy shot in the United States. 5-hour ENERGY's entry into Fortnite comes as the gaming industry is leveling up in scale of the audience and cultural impact, as research by Newzoo has found that 72% of 35-54s and 46% of over 55s game at least once a week. The Flavor Wars custom Unreal Editor for Fortnite map launches Tuesday, August 13 at 10:30 a.m. PST. Fans will compete battle royale-style in a custom-built map by Zoned, divided into three distinct zones representing the 5-hour ENERGY Gamer Shot flavors: Apple Bash, Pineapple Charge and Rocket Raspberry.
|
VIVK | Hot Stocks08:56 EDT Vivakor forms petroleum marketing division - Vivakor has formed a new business unit, Vivakor Supply & Trading, focusing on petroleum marketing operations. Vivakor management intends that VST will bolster operations, diversify revenue streams, and manage market risk at the Company's Delhi, Louisiana and Colorado City, Texas facilities through petroleum marketing activities. In addition, VST's marketing operations will complement the activities of the Endeavor Entities upon closing of the Company's acquisition thereof, as previously announced.
|
GNLN | Hot Stocks08:55 EDT Greenlane announces purchases of shares by CEO Barbara Sher - Greenlane Holdings announced that its Chief Executive Officer, Barbara Sher, acquired 12,500 common shares of Greenlane on the open market between August 5th and August 9th at an average price of $2.66 per Common Share. The purchase of Common Shares by the Chief Executive Officer of the Company reflects confidence in the intrinsic value of the stock and the near-term and long-term growth prospects of the Company
|
FRZA VEEE | Hot Stocks08:50 EDT Forza X1 suspends Q2 results due to Twin Vee merger agreement - Forza X1, Inc. (FRZA) stated that, in light of the Merger Agreement between Forza and Twin Vee PowerCats Co. (VEEE) that was announced yesterday afternoon via 8-K, its conference call and audio webcast originally scheduled for Wednesday, August 14, 2024, at 2:00 p.m. will no longer be taking place.
|
MOBQ | Hot Stocks08:49 EDT Mobiquity Technologies partners with Context Networks - Mobiquity Technologies announces a strategic partnership with Context Networks, a leading programmatic advertising platform leveraging private blockchain technology for the global gaming industry. This collaboration aims to harness the unrealized potential within the casino gaming sector by introducing innovative advertising solutions for slot machines, combining Mobiquity's advanced contextual targeting capabilities with Context Networks' robust blockchain and AI technologies. Through this partnership, Mobiquity Technologies and Context Networks aim to transform how advertising is conducted within casinos.
|
INBS | Hot Stocks08:48 EDT Intelligent Bio Solutions highlights growing need for drug testing solutions - Intelligent Bio Solutions provides an overview of the increasing prevalence of on-the-job drug use across critical sectors such as construction, manufacturing, transport and warehousing, mining, and automotive. The company said, "As the need for robust drug testing solutions intensifies, we believe that our company is positioned to lead the way in providing innovative, non-invasive drug testing technologies... As awareness of the increasing prevalence of on-the-job drug use in critical sectors grows, so does the demand for effective drug testing solutions. Intelligent Bio Solutions understands the critical need for robust drug screening processes that can help businesses maintain a safe and productive work environment. Our Intelligent Fingerprinting Drug Screening System is designed to offer a non-invasive, efficient, and reliable method for employers to safeguard their workforce. Considering this growing concern, our growth remains strong, and we are gaining momentum by expanding into new markets and expanding with new accounts."
|
LQDT | Hot Stocks08:47 EDT Pike County Sheriff's Office conducting foreclosure sales with Bid4Assets.com - The Pike County, Pennsylvania sheriff's office has selected Bid4Assets to host their first-ever online sheriff's sales.
|
RDVT | Hot Stocks08:46 EDT Red Violet's Interactive Data is now available on Carahsoft's GSA schedule - Interactive Data, a red violet company, announced it has been awarded the General Services Administration, GSA, MAS8F 47QSWA18D008F contract through its strategic alliance with Carahsoft Technology Corp., The Trusted Government IT Solutions Provider. As of August 6, 2024, government agencies are now able to procure IDI's next-generation investigative solution, idiCORE, and associated IDI products and services with ease and confidence through Carahsoft's GSA Schedule contract. This strategic alliance is a significant step in IDI's commitment to deliver innovative solutions and drive operational success and security for the public sector and the nation at large.
|
RBBN | Hot Stocks08:46 EDT Ribbon Communications CFO Mick Lopez to retire in Q4 - Ribbon Communications EVP and CFO Miguel Lopez intends to retire after 40 years in the technology industry. Ribbon has engaged an executive search firm to identify and evaluate potential successors from inside and outside the company. Lopez is expected to continue to serve as CFO until a successor is named.
|
SAR | Hot Stocks08:45 EDT Saratoga Investment announces distribution of proxy materials for annual meeting - Saratoga Investment announced that the Company commenced distribution of proxy materials to the Company's stockholders for the 2024 Annual Meeting of Stockholders to be held on September 26 2024. Saratoga's Annual Report on Form 10-K for the year ended February 29, 2024, and its definitive proxy statement for the Annual Meeting which was filed on August 1, 2024 with the U.S. Securities and Exchange Commission.
|
SIDU | Hot Stocks08:45 EDT Sidus Space in deal with Xiomas for FeatherEdge system for fire detection - Sidus Space announces the sale of its FeatherEdge onboard computing system to Xiomas Technologies as part of a groundbreaking project aimed at revolutionizing fire detection. This collaborative effort, involving Sidus Space, Xiomas Technologies, NASA, and Harvard University, will demonstrate rapid fire detection capabilities using a stratospheric balloon platform. The FeatherEdge system, purchased by Xiomas Technologies, will be pivotal in processing high-resolution thermal images captured by Xiomas' advanced infrared sensor. FeatherEdge will perform critical edge computing tasks, compressing raw data into smaller, actionable analytics for efficient transmission to ground stations to demonstrate the ability to deliver crucial information quickly even when bandwidth might be limited. The FeatherEdge system will generate essential data, including the location, size, and intensity of detected heat signatures, which will be packaged into compact packets for near real-time transmission. The stratospheric balloon is scheduled for launch in October 2024, marking a significant advancement in the development of rapid-fire detection technologies.
|
TGL | Hot Stocks08:45 EDT Treasure Global announces integration of TikTok shop in ZSTORE - Treasure Global announce plans to integrate TikTok Shop with ZSTORE, an online store offering a wide range of groceries within the ZCITY Super APP. This integration will enable the Company to showcase and sell products directly within the TikTok Shop, a video-focused social media platform with over 150 million viewers. The integration with TikTok Shop represents a strategic advancement for the Company, driving its globalization efforts and significantly broadening the market reach of ZSTORE. By tapping into TikTok Shop's extensive user base, which includes over 55 million US shoppers, the Company is poised to enhance its global footprint and deliver its innovative solutions and diverse product range to a wider international audience.
|
BRFH | Hot Stocks08:44 EDT Barfresh Food Group announces non-dilutive litigation financing - Barfresh Food Group received multiple offers to fund its lawsuit on a non-recourse non-dilutive basis based on the merits of its legal case. The Company entered into an agreement with a well-known alternative asset investment firm and the Company's litigation counsel, Boesch Law Group, to provide non-recourse non-dilutive litigation financing. Barfresh has spent approximately $300,000 over the past two years for this lawsuit which affected its operating margins. This new non-recourse non-dilutive financing removes the need for additional cash from the Company to fund this pending lawsuit.
|
AIRJ | Hot Stocks08:44 EDT Montana Technologies Corp. to restate previously issued financial statements - Montana Technologies will be restating its previously issued unaudited financial statements for the three months ended March 31, 2024. Investors should no longer rely upon the previously issued financial statements cited above. Similarly, any earnings releases and other investor communications derived from such financial statements should no longer be relied upon. The Company's Board of Directors, in consultation with management and upon the recommendation of the Audit Committee of the Board of Directors, made the decision to restate the first quarter financial statements following the results of a Company-initiated consultation process with the Securities and Exchange Commission. In the Company's first quarter financial statements, the Company consolidated the assets and operations of its AirJoule joint venture into its financial statements, but the Company has subsequently determined that the Company's interest in the AirJoule joint venture should instead have been accounted for based upon the equity method of accounting. The Company intends to correct the error referenced above in an amendment to its Form 10-Q initially filed with the SEC on May 20, 2024 for the quarter ended March 31, 2024. The amendment will be filed with the SEC as soon as possible.
|
AGFY | Hot Stocks08:42 EDT Agrify announces results from annual meeting of stockholders - Agrify Corporation announced voting results from the Company's Annual Meeting of Stockholders on August 12, 2024. At the Annual Meeting, all items of business were considered, as further described in the Company's definitive proxy statement and the supplement thereto. At the Annual Meeting, approximately 49.16% of the Company's outstanding shares of common stock were represented in person or by proxy, representing a quorum. The director nominees Raymond Chang, I-Tseng Jenny Chan, Max Holtzman, Timothy Mahoney, and Krishnan Varier were each re-elected to the Company's Board of Directors. Each director nominee received a plurality of votes cast at the Annual Meeting. With the election of all of the director nominees, Agrify currently has five directors. With more than 97.2% of the votes cast "For," stockholders ratified GuzmanGray as the Company's independent registered public accounting firm for the year ending Dec. 31, 2024. The proposal to approve an amendment to the Company's Articles of Incorporation to effect a reverse stock split of the shares of the Company's common stock at a ratio of not less than 1-for-2 and not greater than 1-for-20, with the exact ratio of, effective time of and decision to implement the reverse stock split to be determined by the Board of Directors, requiring a majority of the Company's outstanding shares of common stock, was not approved. The proposal, as required by Nasdaq Listing Rule 5635, to approve an amendment to the pre-funded warrants issued by the Company on May 21, 2024 to increase in the number of shares of Common Stock underlying such warrants upon the occurrence of certain equity issuances, passed. This proposal received 96.3% of the votes cast "For" the proposal. The proposal for the amendment to the Agrify Corporation 2022 Omnibus Equity Incentive Plan to increase the number of shares of Common Stock available for issuance thereunder by 2,500,000 passed. This proposal received 96.3% of the votes cast "For" the proposal. The proposal to adjourn the Annual Meeting, if necessary, to solicit additional proxies if there were not sufficient votes in favor of any of the forgoing proposals at the time of the annual meeting was approved with 94.2% of the votes cast "For" the proposal. However, the Company elected not to adjourn the meeting to solicit additional proxies for the Reverse Stock Split Proposal.
|
MBOT | Hot Stocks08:41 EDT Microbot receives certification to support future regulatory submissions - Microbot Medical announces it has received ISO 13485:2016 certification for its quality management system. Receiving ISO 13485 certification indicates that a company has developed and implemented robust policies and procedures for the development and manufacture of regulated medical products. "I am extremely proud of the efforts by the entire Microbot team," said Noa Ofer, PhD, Sr. Director of Quality Assurance and Regulatory Affairs. "An ISO 13485 audit is a very extensive process, and our certification is a testament that we are building the right capabilities and infrastructure as we progress toward commercialization."
|
KO MDLZ | Hot Stocks08:41 EDT Coca-Cola, OREO brands partner to launch limited-edition drink, cookie - Coca-Cola (KO) and the OREO (MDLZ) brands have teamed up as "Besties" to create two exclusive and limited-edition products: OREO Coca-Cola Sandwich Cookie and Coca-Cola OREO Zero Sugar Limited Edition. Inspired by besties around the world, the two iconic brands are, for a limited time, sparking celebration amongst besties with the launch of two legendary products and several unique digital and physical experiences.
|
REPL | Hot Stocks08:39 EDT Replimune announces first patient dosed in IGNYTE-3 trial - Replimune Group announced that the first patient has been randomized and dosed in the IGNYTE-3 study - a global Phase 3 clinical trial assessing the efficacy and safety of RP1 plus nivolumab in patients with advanced melanoma who have progressed on anti-PD1 and anti-CTLA-4 drugs or are ineligible for anti-CTLA-4 treatment. "The start of the IGNYTE-3 trial and randomization of the first patient is an important milestone in advance of our planned BLA submission of RP1 in advanced melanoma later this year," said Kostas Xynos, MD, PhD, MBA, Chief Medical Officer at Replimune. "This trial is important because it is intended to both support global regulatory interactions and access, and to serve to confirm the clinical benefit reported from the registration intended Phase 2 IGNYTE cohort in anti-PD1 failed melanoma in June."
|
DARE | Hot Stocks08:39 EDT Dare Bioscience announces additional data for Phase 2b RESPOND study - Dare Bioscience announced that additional data from the exploratory Phase 2b RESPOND clinical study of Sildenafil Cream, 3.6%, an investigational topical cream formulation of sildenafil being developed as an on-demand treatment for female sexual arousal disorder, has been published by The Journal of Sexual Medicine. "In this first-of-its-kind study in FSAD patients, we are very pleased to be able to share these data," said Sabrina Martucci Johnson, President and CEO of Dare Bioscience. "Being able to show consistent results from patient reported outcome measures, regardless of whether she is recalling her experiences over the last month or the last day, provides important optionality as we consider how to clinically measure the impact of Sildenafil Cream on patients with FSAD."
|
AKTS | Hot Stocks08:37 EDT Akoustis receives an additional purchase order for $13M XBAW filters - Akoustis Technologies announced that the Company has received an additional purchase order for $13M from an existing Tier-1 customer to satisfy the customer's demand for seven1 Wi-Fi Access Points production programs. The collaboration highlights the robust relationship with this Wi-Fi Access Point customer. Including the prior $8M PO announced previously, the purchase orders are valued at greater than $21 Million and the arrangement also allows the customer to purchase additional quantities of XBAW RF filters depending on demand of their Wi-Fi AP product.
|
PRPH | Hot Stocks08:37 EDT ProPhase Labs announces collaboration with Forward Heathcare Consultants - ProPhase Labs reported its collaboration with Forward Healthcare Consultants to bring its BE-Smart test for esophageal cancer to market. The experts at FHC will assist with securing market access by focusing on clinical validation and commercialization planning, to include coverage, pricing, and coding. Additionally, FHC will bring its vast relationships with physician networks to drive commercialization success. The consultants at FHC have decades' worth of combined experience in commercializing new healthcare technologies by developing clinical and economic value propositions, comprehensive market access programs, and innovative marketing strategies. They have held leadership positions in provider groups, regional health systems, a multi-state health insurance plan, diagnostic labs, and companies in the medical benefits management, healthcare IT, and precision oncology sectors. Previously serving as leaders for such companies as Eurofins, Guardant Health, Inivata, and Natera, these advisors have helped their former companies gain market access to achieve market capitalization in the billions of dollars. In the coming months, FHC will chart pathways to clinical validation and regulatory and market adoption of ProPhase's breakthrough technology with the goal of achieving similar success to their former companies.
|
SVRE | Hot Stocks08:36 EDT SaverOne 2014 announces it will install its SaverOne system for Egged Tours - SaverOne 2014 announced that it will install its SaverOne system to prevent cell phone distractions by bus drivers in all the buses of Egged Tour's central hub, following a successful pilot project. The follow-on project will install the SaverOne system on 60 buses, in addition to the 70 buses already equipped with the system at Egged Tours hubs across the country. This will cover Egged Tours' entire fleet at its central hub of 130 vehicles. SaverOne's system will help drivers stay fully focused on driving, free from smartphone distractions, while passengers can continue to use their phones as usual.
|
FLS | Hot Stocks08:34 EDT Flowserve to acquire MOGAS Industries for $290M - Flowserve announced that it has signed a definitive agreement to acquire MOGAS Industries, a privately held, Houston-based provider of severe service valves and associated aftermarket services for $290M with a potential $15M earnout. The transaction is expected to close in the fourth quarter of 2024. Founded in 1973, MOGAS was established by V. Louis Mogas with the purchase of a small machine shop. MOGAS has established sales and service offices in Australia, China, Europe, Canada, South America, the Middle East and India, countries which are highly complementary to Flowserve's served geographies. The transaction includes an upfront purchase price of $290M of cash consideration with an additional earnout of up to $15M tied to the achievement of certain minimum levels of adjusted EBITDA of the MOGAS business for the calendar year ended December 31. When adjusted for approximately $15M of expected tax benefits, the upfront purchase price represents a purchase multiple of approximately 7.5x MOGAS' 2024E adjusted EBITDA. The transaction is expected to be accretive to Flowserve's adjusted EPS in the first full year following closing. MOGAS expects to contribute revenues of approximately $200M with adjusted EBITDA margins in the high teens. The additional scale, footprint consolidation and procurement opportunities provided by the combination provide clear visibility to at least $15M of run-rate cost synergies within two years after closing of the transaction. Further, the transaction is expected to increase Flowserve's aftermarket potential and provide the opportunity for revenue growth synergies as well. Flowserve expects to fund the upfront cash consideration through a combination of cash and available debt financing. The transaction is subject to the satisfaction of customary closing conditions and regulatory approvals.
|
GNPX | Hot Stocks08:34 EDT Genprex granted patent in Singapore for Reqorsa gene therapy - Genprex has been granted a patent by the Singapore Patent Office that covers the use of the company's lead drug candidate, Reqorsa Gene Therapy, in combination with anti-PD-1 antibodies through 2037. This patent expands on the previously granted patents in the U.S., Japan, Mexico, Russia, Australia, Chile, China and Korea to cover the use of REQORSA in combination with an immune checkpoint inhibitor, i.e., PD-1 antibodies. The granted Korean patent also claims the use of REQORSA in combination with PD-L1 antibodies. Genprex will be pursuing additional patent applications with claims to combinations of REQORSA and PD-L1 antibodies in the US, Brazil, Canada, China, Europe and Israel. Should these applications grant, they would be applicable to Genprex's Acclaim-3 clinical trial. The Acclaim-3 study is a Phase 1/2 clinical trial that uses a combination of REQORSA and Genentech's Tecentriq as maintenance therapy for patients with extensive stage small cell lung cancer (ES-SCLC) who developed tumor progression after receiving Tecentriq and chemotherapy as initial standard treatment. The Acclaim-3 clinical trial has received FDA Fast Track Designation for this patient population, and Acclaim-3 has received FDA Orphan Drug Designation.
|
SHIM | Hot Stocks08:34 EDT Shimmick updates Q2 earnings conference call date - Shimmick Corporation updated their earnings call date to review its earnings results on Friday, August 16, 2024 beginning at 8:30am ET. The call had previously been scheduled for Thursday, August 15, 2024. The Company will release its second quarter 2024 results after the market close on Thursday, August 15, 2024, as originally planned.
|
LXRX | Hot Stocks08:33 EDT Lexicon to focus on targeted promotion of INPEFA, reduce headcount by over 75 - Lexicon Pharmaceuticals announced that, following a strategic review of its commercial and pipeline programs, it will refocus resources across the portfolio in support of opportunities where the company believes it can have the greatest impact on patients. As a result, the company will optimize its promotional efforts for INPEFA in heart failure and reallocate resources to effectively support the potential commercial launch of ZYNQUISTA for improvement of glycemic control in adults with type 1 diabetes and chronic kidney disease. These efforts are designed to create efficiencies in the company's commercial efforts to promote both INPEFA and ZYNQUISTA. The company expects these efforts to result in cost savings of approximately $40 million for 2025 while ensuring all R&D programs including the pivotal Phase 3 study of sotagliflozin in hypertophic cardiomyopathy and the ongoing Phase 2b dose optimization study of LX9211 in diabetic neuropathic pain are fully funded. In alignment with this reprioritization of resources, the company is planning the following actions with the objective of reducing operational expenses and ensuring the company is right-sized for future opportunities: Reduction of headcount by more than 75, or approximately 50% of its current field force, by the end of the third quarter of 2024. Targeted continuing promotion for INPEFA in heart failure dedicated to growth and expanding market access. Proper investment in the potential launch of ZYNQUISTA for improvement of glycemic control in adults with type 1 diabetes and CKD. Fully investing in our R&D programs including the recently-initiated pivotal Phase 3 study of sotagliflozin in HCM, the ongoing Phase 2b dose optimization study of LX9211 in diabetic neuropathic pain with data expected in the first half of 2025, and IND-enabling studies of LX9851 for obesity and weight management.
|
HD | Hot Stocks08:32 EDT Home Depot cuts FY24 gross margin view to ~33.5% from ~33.9% - Cuts FY24: Operating margin rate to 13.5%-13.6% from approximately 14.1%; Tax rate to approximately 24% from approximately 24.5%. Sees FY24 net interest expense approximately $2.2B vs. prior view approximately $1.8B. Still sees approximately 12 new stores. Says 53rd week expected to contribute approximately 30c of diluted earnings per share.
|
FE | Hot Stocks08:31 EDT FirstEnergy resolves proceedings with Ohio Attorney General, Summit Cty. offices - FirstEnergy has reached an agreement, effective Aug. 12, 2024, with the Office of the Ohio Attorney General and the Office of the Summit County Prosecutor to resolve all outstanding proceedings between the parties.
|
MCHP | Hot Stocks08:30 EDT Microchip, Acacia collaborate to enable data center interconnect systems - Microchip Technology announces that it has worked with Acacia to demonstrate the fourth generation of interoperability between Microchip's META-DX2 Ethernet PHY family and Acacia's Coherent Interconnect Module 8. The two companies' interoperable devices enable low-power, bandwidth-optimized, scalable solutions for pluggable optics in DCI and transport networks. They deliver three key benefits as they jointly enable high-capacity, multi-rate muxponders for optical transport platforms: Optimized DCI bandwidth; Reduced design risk; Better support for full bandwidth, multi-rate operation.
|
TKNO | Hot Stocks08:28 EDT Alpha Teknova launches two new offerings - Alpha Teknova launched two new offerings to provide customers with increased product customization options: Express-Tek Production, to expedite the manufacturing and delivery of critical customer reagents, and a new manufacturing grade, RUO+, that enables customers to scale efficiently from discovery through process development and into clinical manufacturing.
|
URGN | Hot Stocks08:27 EDT UroGen Pharma says ahead of schedule to complete UGN-102 NDA - The latest DOR data is expected to support a new drug application, or NDA, for UGN-102 as a treatment for LG-IR-NMIBC, which the company plans to complete in the very near term. There is potential for an FDA decision as early as the first quarter of 2025, assuming the FDA grants priority review. UroGen initiated submission of the rolling NDA for UGN-102 in January.
|
APLM | Hot Stocks08:27 EDT Apollomics announces preliminary data on vebreltinib - Apollomics announced today positive preliminary clinical data for the cohort of patients with non-CNS MET fusion solid tumors from the Phase 2 SPARTA trial of vebreltinib. Key preliminary clinical data highlights from 14 patients by RECIST v1.1: 43% objective response rate: Six confirmed responses by RECIST 1.1 criteria, out of 14 evaluable patients including one complete response in third-line metastatic NSCLC and five partial responses. Median overall survival was 12.4 months and median progression free survival was 4.5 months. 5.6 months median duration of response and 3.7 months median time to response. The longest duration of response is 18 months, with that patient currently continuing treatment.
|
SAIC | Hot Stocks08:27 EDT SAIC awarded $120M contract for war game support by U.S. Navy - Science Applications International has been awarded a $120M, five-year, cost-plus fixed-fee contract by Naval Supply Systems Command, NAVSUP, to continue the support of Tactical Training Group Pacific's or TTGP, fleet training mission. To date, SAIC has provided Navy tactical course and fleet training requirement support under contracts spanning both the East and West coast Tactical and Expeditionary Warfare school houses. SAIC's scenario creation, training plans and instructor development programs provide efficient solutions to evolving TTGP requirements while offering the lowest transition risk to meet this complex mission.
|
SKWD | Hot Stocks08:26 EDT Skyward Specialty Insurance enters mortgage insurance market - Skyward Specialty Insurance Group announced its entry into the mortgage (re)insurance market. In support of this new venture, Jean-Philippe "JP" Latour joined the Company as senior vice president in May 2024. Latour brings with him a wealth of expertise, having begun his insurance career with Arch in 2013, where he played a pivotal role in developing reinsurance solutions for the primary mortgage market and government-sponsored enterprises. More recently, Latour led Vantage Risk's entry into the Mortgage Reinsurance market.
|
NDRA | Hot Stocks08:22 EDT Endra Life Sciences CEO Francois Michelon steps down - Endra Life Sciences announced its board of directors has appointed Alexander Tokman as acting CEO to replace Francois Michelon, who stepped down from his role as CEO and as a member of the board of directors to pursue other endeavors. The company also announced the addition to its senior management team of Ziad Rouag as head of regulatory and clinical affairs and Richard Jacroux as CFO.
|
ENVB | Hot Stocks08:15 EDT Enveric Biosciences eligible for $61M in radiation dermatitis deal with Aries - Enveric Biosciences and Aries Science & Technology , a developer of encapsulation technologies, today announced that Patent No. 12,059,393 was issued on August 13, 2024, to Enveric's wholly-owned subsidiary, Akos Biosciences or Akos. We believe the newly issued intellectual property strengthens Enveric's patent portfolio. On July 15 , Enveric announced entering into a Licensing Agreement between Aries and Akos for the clinical development of Enveric's now-patented topical product for radiation dermatitis and other conditions. "The additional patent issuance greatly enhances investment potential in the subsidiary being formed by Aries to advance a CBD-based lotion, which has demonstrated promising preliminary results in early-stage animal tests conducted by Enveric," said Dr. Ramanathan Lalgudi, Founder and CEO of Aries. "We believe the newly issued patent is key to launching a protectable and proprietary formulation, as we work to develop treatments to reduce the side effects and increase the tolerance of radiation therapy and enhance the life of millions of cancer patients suffering from radiation dermatitis." ...Under the terms of the Licensing Agreement with Aries, assuming success in meeting all conditions in the Licensing Agreement, Enveric will be eligible to receive aggregate milestone payments of up to $61M , as well as tiered royalties ranging from 2.5% to 10% on future sales.
|
EVOK | Hot Stocks08:15 EDT Evoke Pharma sees cash runway into 2Q25 - As of June 30, 2024, cash and cash equivalents were approximately $9.2 million. We believe, based on our current operating plan, that our existing cash and cash equivalents, as well as future cash flows from net product sales of GIMOTI, will be sufficient to fund our operations into the second quarter of 2025.
|
IINN | Hot Stocks08:14 EDT Inspira Technologies' ART100 system selected by medical tech company - Inspira Technologies was approached by a medical technology company in the industry to evaluate the operation of its proprietary key product in combination with the Inspira ART100 system. The evaluation was conducted by Inspira researchers. The test results exceeded 100% of the standard value for gas transfer at maximum flow. This series of evaluations confirmed that the integrated system met the specified requirements, performing to expectations without any technical malfunctions or abnormal effects on the blood.
|
RYDE | Hot Stocks08:14 EDT Ryde Group announces strategic partnership with Singlife - Ryde Group announced a strategic partnership with Singlife. This collaboration aims to redefine ride-sharing safety and provide protection across different insurance services for both riders and driver-partners. Ryde and Singlife will cross-collaborate to create products and services.
|
CYD RYCEY | Hot Stocks08:11 EDT China Yuchai and Rolls-Royce Systems expand JV operations - China Yuchai (CYD), through its main operating subsidiary in China, Guangxi Yuchai Machinery, announced that Yuchai's Marine and Genset Power subsidiary and Rolls-Royce's (RYCEY) Power Systems division signed an agreement to enter into a second phase cooperation and development of their 50/50 joint-venture entity MTU Yuchai Power. MTU Yuchai Power will extend the production and localization of the mtu Series 4000 for both Power Generation and Oil & Gas segments. The joint venture will also undertake the production and sales of the mtu Series 2000 and the Yuchai branded VC series diesel engines to address the rapid growth in domestic and overseas power generation markets, with its second phase scheduled to commence mass production and operation in the second half of 2025.
|
CMG SBUX | Hot Stocks08:10 EDT Chipotle falls 9% to $51 after CEO leaves for Starbucks
|
EVLV | Hot Stocks08:10 EDT Evolv issued patent by USPTO for Evolv Express - Evolv was awarded a patent issued by the United States Patent and Trademark Office, or USPTO, that covers the differentiating technology used in its flagship product, Evolv Express. Integrated as a concealed weapons detection layer in a venue's overall safety plan, the Evolv Express weapons detection system, is deployed in over a thousand stadiums, theme parks, schools, hospitals and other public spaces around the world.
|
OVID | Hot Stocks08:10 EDT Ovid Therapeutics actively evaluating pipeline - Ovid is actively evaluating its pipeline and undertaking an ongoing process to review indication and development strategies. As part of this process, the Company has currently focused resources on advancing OV888/GV101 and OV329 oral programs toward significant clinical milestones. It also paused the intravenous OV329 program and other preclinical programs.
|
SBUX | Hot Stocks08:09 EDT Starbucks extends rally, shares up 10% to $85 after CEO change
|
OVID | Hot Stocks08:09 EDT Ovid Therapeutics reduces headcount by 43% - The Company streamlined its workforce by reducing 17 positions, or 43% of its headcount, to prioritize its core programs and extend its cash runway. Ovid expects to incur $3.4 million of cash expenditures related to the restructuring. The cash expenditures will be completed by mid-2025.
|
OVID | Hot Stocks08:08 EDT Ovid Therapeutics reports cash position of $77M as of June 30 - Maintained strong financial position of $77.0 million in cash and marketable securities as of June 30, 2024, which are expected to support operations and the potential to achieve five clinical and regulatory milestones by late H1 2026
|
AMIX | Hot Stocks08:08 EDT Autonomix announces upcoming milestones - Expected Upcoming Milestones: Q3 CY2024: Report 4-6 week data from first five lead-in patients in ongoing PoC human clinical trial; Q4 CY2024: Complete enrollment in PoC human clinical trial evaluating proprietary ablation technology for treatment of pancreatic cancer pain; 2024: Complete ablation device design intended for clinical use; 1H 2025: Report topline data from PoC human clinical trial; 2025: Complete development of ablation system and catheters in preparation for human pivotal trial; 2025: Initiate combined sensing / ablation clinical trial; 2026: De novo submission; and 2027: FDA clearance.
|
NRBO | Hot Stocks08:07 EDT NeuroBo Pharmaceuticals completes enrollment in Phase 1 trial of DA-1726 - NeuroBo Pharmaceuticals completed enrollment of the single ascending dose Part 1 of its Phase 1 clinical trial of DA-1726, a novel, dual oxyntomodulin analog agonist that functions as a glucagon-like peptide-1 receptor and glucagon receptor, for the treatment of obesity. A total of 45 participants have been enrolled. Data presented at the American Diabetes Association 84th Scientific Sessions showed that DA-1726 demonstrated superior weight loss compared to survodutide, a drug with the same mechanism of action, while also demonstrating retention of relative lean body mass preservation compared to survodutide while also exhibiting superior glucose lowering. NeuroBo expects to report top-line data from the SAD Part 1 portion of the Phase 1 clinical trial in Q3 of this year and top-line data from the MAD Part 2 in Q1 2025. Further, upon clearance of an updated Investigational New Drug application with the FDA, expects to dose the first patient in the planned Part 3 of the trial during Q3 2025, providing an interim data readout in or around mid-2026 and issuing top-line results in the second half of 2026. Part 2, currently enrolling subjects, is designed as a MAD study, and is expected to enroll approximately 36 participants. The primary endpoint of the Phase 1 trial will assess the safety and tolerability of DA-1726.
|
SBUX CMG | Hot Stocks08:07 EDT Starbucks jumps 7% to $82.30 after naming Chipotle's Niccol as CEO - Shares of Chipotle Mexican Grill (CMG) are down 8% to $51.50.
|
SBUX CMG | Hot Stocks08:07 EDT Starbucks CEO Laxman Narasimhan steps down, Brian Niccol to succeed - Starbucks (SBUX) announced that Brian Niccol has been appointed chairman and chief executive officer. Niccol will start in his new role on September 9. Starbucks chief financial officer, Rachel Ruggeri, will serve as interim CEO until that time. Mellody Hobson, Starbucks board chair, will become lead independent director. Niccol currently serves as chairman and CEO of Chipotle (CMG). Laxman Narasimhan is stepping down from his role as CEO and as a member of the Starbucks board with immediate effect.
|
CMG SBUX | Hot Stocks08:07 EDT Chipotle CEO Brian Niccol to depart, Scott Boatwright named interim CEO - Chipotle Mexican Grill (CMG) announced that Brian Niccol, Chairman and CEO has accepted the role as Chairman and Chief Executive Officer of Starbucks (SBUX) and will be leaving the company effective August 31. Niccol has served as Chipotle's CEO since 2018 and as Chairman of the Board since 2020. Chipotle's Board of Directors has appointed Scott Boatwright, COO, as Interim CEO. Boatwright joined Chipotle in 2017 and has been instrumental in driving restaurant operations for the company's more than 120,000 employees and over 3,500 restaurants. In addition, Jack Hartung, who recently announced his retirement from Chipotle in 2025, has agreed to remain with the organization indefinitely as President of Strategy, Finance and Supply Chain to ensure a smooth transition. In this new role, Hartung will support Boatwright as Interim CEO, and continue his current oversight of Adam Rymer, Vice President of Finance and incoming CFO, as well as Carlos Londono, global head of Supply Chain.
|
SBUX CMG | Hot Stocks08:06 EDT Starbucks names Chipotle's Brian Niccol as chairman and CEO
|
CMG | Hot Stocks08:05 EDT Chipotle CEO Brian Niccol to depart, Scott Boatwright named interim CEO
|
GALT | Hot Stocks08:04 EDT Galectin Therapeutics sees cash runway through May 15, 2025 - As of June 30, 2024, the Company had $25.6 million of cash and cash equivalents. Additionally, the Company has $10 million remaining available under a line of credit provided by its chairman of the board to fund operations. The Company believes it has sufficient cash to fund currently planned operations and research and development activities through approximately May 15, 2025.
|
QLI | Hot Stocks08:04 EDT Qilian International announces ticker symbol change to 'BGM' - Qilian International Holding announced that effective on August 11, its Class A ordinary shares will begin trading on the Nasdaq Capital Market under the ticker symbol "BGM". The new ticker symbol will replace the company's current ticker symbol "QLI." No action by the company's shareholders is required with respect to the ticker symbol change. The Company's Class A ordinary shares will continue to be listed on the Nasdaq Capital Market and the CUSIP number remains unchanged.
|
OKLO | Hot Stocks08:04 EDT Oklo establishes preferred supplier agreement with Siemens Energy - Oklo (OKLO) announced a key strategic development in its supply chain management by signing a preferred supplier agreement with Siemens Energy (SIEGY) for the power conversion system of the Aurora powerhouse. This agreement underscores Oklo's ambitions to bring cost-efficient advanced fission technology to market. Building on a previously signed Memorandum of Understanding, this binding agreement marks a crucial step in Oklo's vision to enhance production scalability, cost efficiency, and rapid deployment to meet growing customer demand.
|
LDOS | Hot Stocks08:02 EDT Leidos awarded $191M Army mission software modernization contract - Leidos was recently awarded a $191M contract by the Army Contracting Command - Aberdeen Proving Ground for integrated lifecycle software and management solutions in support of the U.S. Army Communications Electronics Command, Software Engineering Center, C3T Directorate, Fires Division. The contract covers a five-year performance period, with a six-month extension option. The safety-critical work Leidos will perform builds upon its prior mission software development for this customer, including by providing cyber-hardened software and systems engineering, technical services and software integration.
|
ACRV | Hot Stocks08:01 EDT Acrivon Therapeutics sees cash runway into 2H26 - As of June 30, 2024, the company had cash, cash equivalents and marketable securities of $220.4 million, which is expected to fund our operating expenses and capital expenditure requirements into the second half of 2026.
|
SLVTF | Hot Stocks07:49 EDT Silver Tiger Metals provides update on PFS drilling program on El Tigre - Silver Tiger Metals provided an update on the first 151 drill holes of the Company's Pre-Feasibility Study drilling program on its El Tigre Project in Sonora, Mexico. These new results are highlighting the high-grade nature of the Keel Zone while expanding near-surface mineralization footprint 700 metres from the Starter Pit. Drill hole ET-24-617 intersected the Stockwork Zone with 96.3 metres grading 100.7 g/t silver equivalent or 1.34 g/t gold equivalent from 2.4 to 98.7 metres, consisting of 0.34 g/t gold and 75.4 g/t silver INCLUDING the high-grade SK Vein with 1.2 metres grading 4,894.1 g/t silver equivalent or 65.25 g/t gold equivalent from 97.5 to 98.7 metres, consisting of 1.96 g/t gold and 4,747.0 g/t silver. This hole highlights the newly discovered high-grade Keel Zone and expands Stockwork Zone 50 meters to east, over the 2023 MRE. New intersections through the Stockwork gold deposit, comprised of the Footwall, Hanging Wall and high-grade Keel Zones, are highlighted. Drill hole ET-24-615: 18.4 metres grading 3.53 g/t gold equivalent or 264.5 g/t silver equivalent from surface to 18.4 metres, consisting of 1.90 g/t gold and 122.2 g/t silver AND 21.9 metres grading 0.86 g/t gold equivalent or 64.8 g/t silver equivalent from 66.3 to 88.2 metres consisting of 0.40 g/t gold and 35.2 g/t silver. The hole has expanded Hanging Wall Zone mineralization 25 metres up dip to surface over 2023 MRE. Drill hole ET-24-616: 31.9 metres grading 1.85 g/t gold equivalent or 138.7 g/t silver equivalent from 61.4 to 93.3 metres, consisting of 0.14 g/t gold and 128.5 g/t silver INCLUDING 1.3 metres grading 37.04 g/t gold equivalent or 2,778.3 g/t silver equivalent from 77.4 to 78.7 metres consisting of 1.07 g/t gold and 2,698.0 g/t silver. The hole confirms Hanging Wall Zone mineralization 700 metres north of Starter Pit and expands mineralization profile 25 metres to the west. Drill hole ET-24-619: 24.7 metres grading 1.06 g/t gold equivalent or 79.9 g/t silver equivalent from 3.3 to 28.0 metres, consisting of 0.39 g/t gold and 50.6 g/t silver AND 18.9 metres grading 0.41 g/t gold equivalent or 30.6 g/t silver equivalent from 41.4 to 60.3 metres consisting of 0.31 g/t gold and 7.4 g/t silver. This hole expands Stockwork mineralization to surface, some 600 metres north of the PEA 'Starter Pit.' Silver Tiger's CEO, Glenn Jessome, stated, "As we progress to release the PFS study, the last round of Resource Drilling assay results continues to highlight the extensive Stockwork Zone mineralization at the El Tigre Project." Mr. Jessome further stated, "The last and final assay results from Geotechnical drilling will be released in the coming weeks, completing the assay results from the PFS study."
|
EGLXF | Hot Stocks07:47 EDT Enthusiast Gaming's Fantasy Football Scout entered into partnership with EFL - Enthusiast Gaming announced that Fantasy Football Scout, the UK's leading fantasy football advice service and a subsidiary of Enthusiast Gaming, has entered into a partnership with the English Football League, EFL, to promote and support Fantasy EFL, a new fantasy game mode launched by the EFL for the 2024/25 season. "Fantasy Football Scout has always been a labour of love, created by fantasy football fans for fantasy football fans and our first mission is serving that incredible community," said Chris James, CEO of Fantasy Football Scout. "I have the pleasure of working with the very best team in the business and serving a truly global audience. The chance to work with the English Football League, part of the fabric of life for hundreds of millions of fans around the world, as well as work on a brand new exciting fantasy game is an absolute privilege, about which we are all very excited."
|
CING | Hot Stocks07:47 EDT Cingulate sees cash runway late into 3Q24 - As of June 30, 2024, Cingulate had $0.4 million in cash and cash equivalents. On July 1, 2024, Cingulate received the net proceeds of $1.6 million from the warrant inducement described above. Management believes this cash on hand will support operating and development costs late into the third quarter of 2024. Management intends to seek opportunities to access additional capital as needed, including non-dilutive capital in terms of potential licensing opportunities inside and outside of the US, and additional equity or debt capital.
|
PSTV | Hot Stocks07:46 EDT Plus Therapeutics presents FORESEE trial results - Plus Therapeutics presented data from the FORESEE study of its CNSide platform for the diagnosis and management of LM. The data were presented in a podium presentation at the 2024 Society for NeuroOncology, SNO/American Society for Clinical Oncology, ASCO, CNS Metastases Conference August 8-10, 2024 in Denver, Colorado. Key results from the FORESEE trial: The trial achieved its primary endpoint, demonstrating that CNSide influenced treatment decisions in over 90% of cases, surpassing the 20% primary endpoint target; CNSide demonstrated enhanced sensitivity in detecting tumor cells (80%) vs. cytology (29%) in patients with LM; CNSide identified actionable mutations in the CSF, such as HER2 amplification, influencing 24% of therapeutic selection decisions; CNSide exhibited high specificity, with no tumor cells detected in patients without LM
|
OPTHF PBM | Hot Stocks07:44 EDT Optimi Health, Psyence Biomedical sign LOI for psilocybin drug development - Optimi Health (OPTHF) and Psyence Biomedical (PBM) have entered into a non-binding Letter of Intent. This arrangement would position Optimi as the exclusive supplier of GMP nature-derived psilocybin extract for Psyence's global drug development and commercialization initiatives for FDA-approved use in the Palliative Care context. Under the terms of the LOI, and subject to the execution of a binding agreement, Optimi will become the exclusive supplier of GMP nature-derived psilocybin extract for Psyence. Optimi will provide comprehensive Chemistry, Manufacturing, and Control support for regulatory submissions related to these trials and any future Investigational New Drug applications. Psyence will obtain exclusive rights to Optimi's drug candidate for treatment use in the Palliative Care context. The successful outcomes of these trials may enable Psyence to commercialize the licensed product, in a way that it believes will revolutionize treatments within the Palliative Care setting. This is a non-binding LOI and there can be no guarantee that the companies will execute a fully binding agreement.
|
POAI | Hot Stocks07:42 EDT Predictive Oncology expands application of its live-cell tumor platform - Predictive Oncology announced that it has expanded the available applications for its platform to account for patient heterogeneity, de-risk drug discovery, and accelerate pipeline development. Responding to the historically high failure rate in drug development in Phase II and Phase III clinical trials, the Company is utilizing its artificial intelligence, active machine learning capabilities, in a CLIA wet lab environment, to leverage its extensive biobank of cryogenically preserved patient-derived live-cell tumor samples, across 137 different tumor types accumulated over nearly two decades, to account for patient heterogeneity ahead of any clinical phase development work.
|
CCBG | Hot Stocks07:41 EDT Capital City Bank promotes Jensen to CTO - Capital City Bank announces Lynne Jensen has been promoted to Chief Technology Officer, CTO. The company said, "As Chief Technology Officer, Jensen will spearhead the development and execution of our comprehensive technology strategy, ensuring alignment with our organizational mission and strategic goals. She will provide strategic and technical direction across product development, cybersecurity, application architecture, artificial intelligence platforms, infrastructure management, budgeting, operational efficiency, associate growth, and future processes and system alterations."
|
KPTSF | Hot Stocks07:40 EDT KP Tissue sees Q3 Adjusted EBITDA in the range of 2Q24 - The company said, "For the third quarter of 2024, we expect Adjusted EBITDA to be in the range of Q2 2024."
|
SOTK | Hot Stocks07:40 EDT Sono-Tek announces additional $2.95M order from clean energy customer - Sono-Tek Corporation announces the receipt of an additional $2.95 million order from an existing clean energy customer. This new order, identical in value and scope to a recent record-breaking order from the same customer, reinforces Sono-Tek's position as a key player in the clean energy sector. The latest order includes four production-scale systems, which are expected to be shipped during fiscal 2026, starting March 1, 2025. This new order builds on the previously announced eight production-scale systems, bringing the total number of production systems for this customer to twelve. Initially starting with an R&D system to develop their processes, the customer has now advanced to a significant production-scale commitment, demonstrating the effectiveness and reliability of Sono-Tek's technology.
|
CYBN | Hot Stocks07:39 EDT Cybin realigns governance, nominating and compensation committees - The company also announced the realignment of the composition of its Governance and Nominating Committee, and Compensation Committee which will now be comprised solely of existing independent Directors Eric Hoskins, Chair , Mark Lawson, and Theresa Firestone; and Grant Froese Mark Lawson and Theresa Firestone, respectively.
|
ZPTA | Hot Stocks07:37 EDT Zapata AI enters CRADA with U.S. Special Operations Command - Zapata Computing Holdings has entered a Cooperative Research and Development Agreement with the U.S. Special Operations Command. Key Highlights of the CRADA include: Empowering USSOCOM with advanced AI tools to enhance situational awareness, real-time decision-making, and operational readiness in challenging environments and contested spaces. Accelerating USSOCOM's ability plan, create, and deliver AI-driven advantage to align closely with specific mission objectives and parameters. Deepening Zapata AI's existing relationship across the United States Department of Defense innovation ecosystem. Under the terms of the CRADA, Zapata AI will leverage its Orquestra platform to speed up the model development lifecycle and create AI and ML applications that enhance mission performance for USSOCOM's Hyper-Enabled Force initiatives. The decision-support capabilities developed by the partnership will run on the edge in low connectivity environments on ruggedized high-performance computing hardware.
|
CYBN | Hot Stocks07:37 EDT Cybin completes FDA Type B initial breakthrough meeting D - Cybin announced that it held a Type B Initial Breakthrough Therapy Meeting with the U.S. Food and Drug Administration late last week in Washington, D.C. The company plans to initiate its Phase 3 pivotal trial of CYB003 for the adjunctive treatment of MDD in late summer of 2024. "Following our productive Type B meeting, we continue to expect to commence our Phase 3 pivotal program in late summer," said Doug Drysdale, Chief Executive Officer of Cybin. "Having selected 30 clinical sites across the United States and Europe, we are eager to initiate this next phase of clinical development and to build on the positive impact of CYB003 to date. In our Phase 2 study, CYB003 showed a robust and sustained effect, with 75% of patients in remission from depression four months after two 16mg doses. We expect to report 12-month efficacy data from the Phase 2 study in the fourth quarter of this year. We look forward to ongoing engagement with the FDA as we advance our path to bringing new, improved treatment options to patients and providers." Further to recent industry discussions around the subject of functional unblinding, the Company plans to implement multiple measures to attempt to mitigate the risk of functional unblinding in its pivotal study program.
|
ABEO | Hot Stocks07:35 EDT Abeona Therapeutics announces favorable medicare reimbursement decisions - Abeona Therapeutics announced that the Centers for Medicare and Medicaid Services, CMS, has granted a product-specific procedure code ICD-10-PCS for prademagene zamikeracel (pz-cel), Abeona's investigational autologous cell-based gene therapy currently in development for recessive dystrophic epidermolysis bullosa, RDEB. If pz-cel receives U.S. marketing approval, this code will allow for efficient and accurate documentation, billing, and analysis of inpatient hospital procedures using pz-cel. The code will go into effect on October 1, 2024.
|
PRTG | Hot Stocks07:35 EDT Portage Biotech announces 1-for-20 reverse stock split - Portage Biotech announced that the Company's Board of Directors approved a reverse stock split of its ordinary shares at a ratio of 1-for-20. Beginning with the opening of trading on August 15, 2024, Portage's ordinary shares are expected to begin trading on The Nasdaq Capital Market on a split-adjusted basis under the existing trading symbol "PRTG" and new CUSIP number G7185A136. The reverse stock split is being implemented to increase the per share trading price of the Company's ordinary shares for the purpose of ensuring a share price high enough to comply with the minimum $1.00 bid price requirement for continued listing on The Nasdaq Capital Market
|
FEAM | Hot Stocks07:34 EDT 5E Advanced Metals supports Fastmarkets relaunch of boric assesments, data - 5E Advanced Materials announces its support for, and applauds the decision by Fastmarkets to relaunch its boric acid price assessments and data. J.T. Starzecki, Chief Strategy Officer of 5E Advanced Materials commented, "We applaud Fastmarkets for the agency's relaunch of a technical-grade boric acid price. We believe this effort enhances overall clarity in market pricing for the commodity, which in turn will help to create a more efficient marketplace and bring more buyers and sellers together. Additionally, we believe this effort underscores the increasing significance of boron and boric acid in the ongoing energy transition and other critically important industries it serves. 5E is dedicated to executing its vision to become a global leader and supplier of boric acid and boron specialty materials, and these price assessments help broaden the visibility of the global boron market. Further, this builds on the growing support that the critical material has received recently from industry, legislators, and federal agencies."
|
BITF | Hot Stocks07:30 EDT Bitfarms updates board, appoints Howlett as Chairman, Wilson as COO - Bitfarms announced updates to its Board of Directors and Executive Team. Ben Gagnon, Chief Executive Officer of Bitfarms, has been appointed to the Company's Board of Directors, effective immediately. The Company also announced today that the Board has appointed Lead Director Brian Howlett as its new independent Chairman. Nicolas Bonta, Founder and former Chairman, has decided to step down from the Board, also effective immediately. The Board will continue to be comprised of five directors, four of whom will be independent. The Company also announced today that Liam Wilson, an experienced executive with over two decades of leadership experience across multiple relevant industries, has been appointed Chief Operating Officer, COO, effective August 26, 2024.
|
ATAI | Hot Stocks07:29 EDT Atai Life Sciences announces preliminary results from Phase 1b trial of VLS-01 - atai Life Sciences announced preliminary results from the Phase 1b trial of VLS-01, its proprietary oral transmucosal film formulation of N,N-dimethyltryptamine that is applied to the buccal surface. The Phase 1b trial was designed to evaluate the relative safety, tolerability, pharmacokinetics and pharmacodynamics of VLS-01 compared to intravenous DMT. The single center, open-label study enrolled a total of 17 healthy participants, each of whom received a single dose of IV DMT followed by 3 different doses of VLS-01 buccal film-20mg, 60mg, 120mg or 160mg-with a 28-day washout window between administrations. Key takeaways: Peak plasma concentrations were dose-proportional and comparable between the higher VLS-01 buccal film doses and the 30mg IV DMT dose; peak plasma concentrations were achieved within 30-45 minutes. Dose-dependent and robust subjective effects were seen at the 120mg and 160mg doses. In the 120mg dose cohort: 13/14 participants achieved Subjective Intensity Rating Scale scores greater than seven out of ten. Subjective effects, assessed with the SIRS, were fully resolved by 120 minutes. Participants reported that the experience was 'psychologically meaningful' with 'increased levels of self-reflection'. Safety and tolerability: VLS-01 demonstrated a favorable safety profile and was well tolerated, with all adverse events classified as either mild or moderate, and most resolving on the day of dosing. The most common treatment-emergent adverse events were headache, dissociation, euphoric mood and nausea. No TEAEs of vomiting or local irritation were noted at doses of 120mg or lower, and only 1 subject out of 14 reported nausea at the 120mg dose. There were no observed adverse events related to blood pressure, heart rate or suicidality. Based on the positive results from the Phase 1b trial, the Company plans to initiate a randomized, double-blind, placebo-controlled Phase 2 study to assess the safety, efficacy and durability of response of repeated doses of VLS-01 in patients with treatment-resistant depression. The Phase 2 trial will consist of two treatment periods. In the first treatment period, approximately 142 patients will be randomized 1:1 to receive a 120mg dose of VLS-01 buccal film or placebo on Day 1, followed by a second dose of the same intervention at Week 2. The primary endpoint is the change from Baseline in Montgomery-Asberg Depression Rating Scale total score at Week 4 and the last double-blind assessment visit will be at Week 14. The first treatment period will provide 12 weeks of durability data following two doses of VLS-01 administered in a placebo-controlled fashion. The second treatment period starts at Week 14 and will explore the response to two different dose levels of VLS-01. Patients will be randomized 1:1 to receive a third dose of either 60mg or 120mg of VLS-01. Final safety and efficacy assessment will be conducted two weeks after administration of the third dose. atai expects to initiate the Phase 2 trial around year-end 2024, with topline data anticipated around year-end 2025.
|
ATAI | Hot Stocks07:27 EDT Atai Life Sciences sees cash runway into 2026 - As of June 30, 2024, the Company had cash, cash equivalents, restricted cash and short-term securities of $103.3 million compared to $154.2 million as of December 31, 2023. The decrease of $50.9 million was primarily driven by $38.8 million net cash used in operating activities, $10 million for the Beckley Psytech investment, and $3.9 million funding of strategic investments. The Company expects its cash, short-term securities, public equity holdings, and committed term loan facility with Hercules Capital, Inc. to be sufficient to fund operations into 2026.
|
CNTA | Hot Stocks07:22 EDT Centessa sees cash runway into mid-2026 - $294.8 million as of June 30, 2024. The Company expects its cash, cash equivalents and short-term investments as of June 30, 2024 will fund operations into mid-2026 without drawing on the remaining available tranches under the Oberland credit facility.
|
MRSN | Hot Stocks07:20 EDT Mersana Therapeutics sees cash runway into 2026 - Cash, cash equivalents and marketable securities as of June 30, 2024 were $162.7 million. Mersana continues to expect that its capital resources will be sufficient to support its current operating plan commitments into 2026.
|
MCRB | Hot Stocks07:10 EDT Seres Therapeutics sees cash runway into 4Q25 upon VOWST sale close - Seres plans to use the capital obtained from the VOWST asset sale transaction to fully retire its senior secured debt facility with Oaktree Capital Management. Additionally, the Bacthera manufacturing contract will be terminated upon close of the transaction, and Seres will have no further obligations to Bacthera. Various VOWST-related capabilities, including product manufacturing, will transition to Nestle Health Science as part of the asset sale. As a result, Seres expects that more than a third of its employees will transfer to Nestle Health Science following the close of the transaction. Moving forward, Seres will be a streamlined and more focused organization, and the Company's cash burn rate is expected to be reduced. As of June 30, 2024, Seres had $71.2 million in cash and cash equivalents. Based on existing cash and operating plans, expected cash to be received upon the close of the VOWST sale and related installment payments due in 2025, and ongoing transaction-related obligations, the Company expects to fund operations into the fourth quarter of 2025. Absent the VOWST sale, the Company expects to fund operations into the fourth quarter of 2024.
|
VERI | Hot Stocks07:07 EDT Veritone announces multi-year agreement with NCAA - Veritone announced a multi-year agreement with the National Collegiate Athletic Association, or NCAA, to serve as its official global archive of record and exclusive, worldwide footage agent for all NCAA championship content. The agreement will leverage Veritone's AI-powered Digital Media Hub platform, including its licensing capabilities, to enhance the storage, management and distribution of the NCAA's championship media assets.
|
VIGL | Hot Stocks07:05 EDT Vigil Neuroscience sees cash runway into 2026 - Cash, cash equivalents, and marketable securities were $86.7 million as of June 30, 2024, compared to $101.6 million as of March 31, 2024. The Company expects its cash, cash equivalents and marketable securities, together with the $40 million gross proceeds received from Sanofi in July, will fund its operational plans into 2026.
|
BAX | Hot Stocks07:04 EDT Baxter targets operation sales growth 4%-5% annually - The company said, "Following the completion of the pending sale of Kidney Care, Baxter is targeting operational sales growth of 4% to 5% annually driven by innovation and continued market expansion. For 2025, the company anticipates an adjusted operating margin1 of approximately 16.5% on a continuing operations basis, which reflects an anticipated 100 basis point negative impact due to stranded costs, net of anticipated transition service agreement (TSA) income, and the manufacturing supply agreement (MSA) the company will enter into upon the completion of the divestiture of the Kidney Care segment. Baxter will continue to prioritize capital allocation and expects to direct investments toward higher-growth, higher-return opportunities to drive incremental value. To support these efforts, the company will continue to focus on deleveraging and expects to reach its investment-grade target of below 3.0X by the end of 2025, after utilizing proceeds from the sale of Kidney Care to repay outstanding debt, which may include repayment of its new bridge facility. Additionally, the company currently expects to fully offset stranded costs and loss of TSA income in 2027 through cost containment initiatives, some of which are already underway, which will further support the company's objective of delivering annual adjusted operating margin expansion."
|
IMTX | Hot Stocks07:04 EDT Immatics sees cash runway into 2027 - Cash and cash equivalents as well as other financial assets total EUR 531.1 million as of June 30, 2024, compared to EUR 425.9 million as of December 31, 2023. The increase is mainly due to the public offering in January 2024, partly offset by ongoing research and development activities. The Company projects a cash runway into 2027.
|
BAX CG | Hot Stocks07:03 EDT Baxter to divest Kidney Care segment to Carlyle for $3.8B - Baxter (BAX) announced that they have signed a definitive agreement under which Carlyle (CG) is to acquire Baxter's Kidney Care segment, to be named Vantive, for $3.8B. Under the terms of the definitive agreement, subject to certain closing adjustments, Baxter will receive approximately $3.5B in cash with net after-tax proceeds currently estimated to be approximately $3B. Baxter announced its intention to create a standalone kidney care company in January 2023. In March, Baxter announced that it was in discussions to explore a potential sale of the segment. Baxter intends to use after-tax proceeds from the transaction to reduce its debt. The business has more than 23,000 employees globally and had 2023 revenues of $4.5B. The transaction is expected to close in late 2024 or early 2025, subject to receipt of customary regulatory approvals and satisfaction of other closing conditions.
|
SNDL | Hot Stocks07:03 EDT SNDL to acquire remaining minority interest in Nova Cannabis for C$40M - SNDL and Nova Cannabis are pleased to announce that they have entered into an arrangement agreement pursuant to which SNDL will acquire all of the issued and outstanding common shares in the capital of Nova not already owned by SNDL, representing approximately 34.8% of Nova Shares, by way of a statutory plan of arrangement for aggregate consideration of approximately C$40M. Under the terms of the Agreement, Nova's shareholders will receive C$1.75 in cash for each Nova Share, representing a premium of 41.2% to the 20-day VWAP of Nova Shares on the Toronto Stock Exchange as of market close on August 12, 2024. The Transaction has been approved by the boards of directors of both SNDL and Nova and is expected to close on or before October 18, 2024. Following the closing of the Transaction, the Nova Shares are expected to be delisted from the TSX and Nova will apply to cease to be a reporting issuer in all provinces and territories of Canada.
|
PEN | Hot Stocks07:02 EDT Penumbra announces $200M share repurchase authorization - Penumbra approved a share repurchase authorization in the amount of up to $200M, allowing Penumbra to repurchase its common stock from time to time at such prices as it deems appropriate through open market purchases, block transactions, privately negotiated transactions, including accelerated share repurchase transactions, or otherwise. The repurchase authorization expires on July 31, 2025. Under this authorization, Penumbra entered into an accelerated share repurchase agreement with JPMorgan Chase Bank on August 12, 2024 to repurchase $100M of Penumbra's common stock. Under the ASR, Penumbra will make an initial payment of $100M to the Dealer and will receive an initial delivery of approximately 474,000 shares of Penumbra's common stock on August 13. The final settlement of the ASR is expected to be completed in Q3. Penumbra is funding the share repurchase under the ASR with cash on hand.
|
IHS MTNOY | Hot Stocks06:50 EDT IHS Holding and MTN Group to discuss resolution to partnership renewal issues - IHS Holding (IHS) and MTN Group (MTNOY) will work to find a mutually agreeable resolution to governance issues previously raised after having recently renewed and extended communications infrastructure deals in Nigeria, as well as completing the renewal of all contracts across IHS Towers-MTN markets recently. On 7 August, the companies announced the agreement to renew and extend all Nigerian tower Master Lease Agreements until December 2032. The contracts include new financial terms that provide what the parties believe to be a more sustainable split between local and foreign currency. With this, IHS Towers and MTN Group have now completed the renewal of approximately 26,000 MTN tenancies on IHS Towers infrastructure across six African markets - Nigeria, Rwanda, Cote d'Ivoire, Cameroon, Zambia and South Africa. MTN Group owns approximately 26% in IHS Towers, a stake which pre-dates the tower company's listing on the NYSE in 2021.
|
CLRB | Hot Stocks06:47 EDT Cellectar Biosciences sees cash balance sufficient into 2Q25 - The company believes its cash balance as of June 30, 2024 of $25.9M, when combined with the $19.4M raised in July, is adequate to fund its basic budgeted operations into Q2 2025. "With our recent positive data announcement from the CLOVER WaM pivotal study evaluating iopofosine I 131 in Waldenstrom's macroglobulinemia, we remain focused on filing our WM NDA in the fourth quarter of this year," said James Caruso, CEO. "We anticipate an accelerated six-month NDA review period and continue to prepare for a potential launch of iopofosine in 2025. We look forward to bringing this meaningful therapy to market and establishing iopofosine I 131 as the standard of care for the treatment of relapsed and refractory WM patients."
|
GCTS SSNLF | Hot Stocks06:46 EDT GCT Semiconductor signs MOU with Samsung - GCT Semiconductor (GCTS) announced the signing of a Memorandum of Understanding with Samsung Electronics (SSNLF) that aims to accelerate the development of 4G/5G chipsets and modules, as well as drive the adoption by device makers. GCT will work together with Samsung to promote the total Samsung/GCT solution and to strengthen the ecosystem of OEM/ODM device makers in order to support wireless operators worldwide, including the Saudi Arabian oil group Aramco, in the 450 MHz and 4.0 GHz business, mission-critical public safety, and more. Samsung will provide test environments as well as interoperability and device testing support for GCT's chipset certification.
|
SRFM PLTR | Hot Stocks06:38 EDT Surf Air Mobility announces plan to form new venture, partners with Palantir - Surf Air Mobility (SRFM) has announced that it intends to form Surf Air Technologies LLC, a new venture that will develop, market, and sell AI-powered software tools to create a category-defining operating system for the advanced air mobility industry. Surf Air Technologies' core platform, "SurfOS", will be powered by Palantir Technologies (PLTR). Surf Air Technologies intends to sell and deploy software tools across the market consisting of thousands of Part 135 regional air operators, of which Surf Air Mobility's Southern Airways subsidiary is the largest by scheduled departures. Palantir and Surf Air will engage their enterprise teams to make this technology broadly available.
|
GIB | Hot Stocks06:33 EDT CGI selected by New York City for maintenance of STARS parking violation system - CGI announced its selection by the City of New York for maintenance of the STARS parking violation system, which runs on CGI Advantage Collections platform. CGI will partner with the city's Department of Finance under a new five-year contract with an optional two-year renewal to administer the adjudication, payment and collection processes for parking and camera violations issued by the city, resulting in the collection of over C$1.3B in public revenue each year. The system supports the city's annual management of approximately 17M parking and camera tickets. Under the new agreement CGI will provide IT and consulting services focused on evolving business environments, system modifications, and new solution designs.
|
TGT | Hot Stocks06:32 EDT Target names Amy Tu chief legal and compliance officer - Target announced that Amy Tu has been named chief legal and compliance officer and corporate secretary effective August 25. In her new role, Tu will lead the company's legal, compliance and corporate governance functions. She succeeds Don Liu, who recently announced his upcoming retirement and will transition to a strategic advisory role. Tu joins Target's leadership team and will report to Brian Cornell, chair and CEO.
|
HD | Hot Stocks06:31 EDT Home Depot falls 3% to $334 after cutting 2024 comp sales outlook
|
UEC | Hot Stocks06:21 EDT Uranium Energy announces restart of ISR uranium production in Wyoming - Uranium Energy announced the successful startup of uranium production at its past-producing Christensen Ranch In-Situ Recovery, or ISR, operations in Wyoming. Production commenced in the previously operated Mine Unit 10 at Christensen Ranch on August 6. To date, uranium concentrations in the initial production patterns are meeting expectations and are anticipated to rise in the coming weeks. All planned startup milestones, including the hiring and training of the initial restart workforce for both the Irigaray Central Processing Plant and Christensen Ranch, have been achieved to ensure a successful ramp-up of uranium production. Approximately 40% of the total workforce is from Johnson County, with other employees originating from Campbell, Converse, Carbon, Laramie and Natrona Counties in Wyoming. The first shipment of yellowcake is anticipated to occur in November or December. This coincides with the company's fiscal Q2 ending January 31, 2025. Uranium recovered from Christensen Ranch will be processed at the Irigaray CPP, located approximately 15 miles northwest of Christensen Ranch. Irigaray has a current licensed capacity of 2.5M pounds U3O8 per year, with a license amendment currently under regulatory review that is expected to increase capacity to 4M pounds annually. The Irigaray CPP is the hub, central to four fully permitted ISR projects in the Powder River Basin of Wyoming, including Christensen Ranch.
|
HUYA | Hot Stocks06:13 EDT Huya declares $1.08 per share special cash dividend - The board of directors of the company has declared a special cash dividend of $1.08 per ordinary share, or $1.08 per ADS, to holders of ordinary shares and holders of ADSs of record as of the close of business on October 9, payable in U.S. dollars. The total amount of cash to be distributed for the special cash dividend is expected to be approximately $250M, which will be funded by surplus cash on the company's balance sheet. The payment date for holders of ordinary shares and holders of ADSs is expected to be on or around October 25. Holders of the company's ADSs will receive the cash dividend through the depositary bank, subject to the terms of the deposit agreement.
|
BEEM | Hot Stocks06:04 EDT Beam Global completes first European EV ARC deployment for UK MOD - Beam Global has deployed the first EV ARC solar-powered EV charging systems for the UK Ministry of Defence at several British Sovereign Bases on Cyprus. This is the first EV ARC customer shipment out of Beam Global's new European facilities. As previously announced, the UK MOD ordered $1M worth of Beam products through Crown Commercial Service which is the main purchasing vehicle for UK government entities. Additional products on order will be delivered in the coming months.
|
HBM | Hot Stocks06:04 EDT Hudbay Minerals backs 2024 consolidated production view - Hudbay has reaffirmed its full year 2024 consolidated production guidance for all metals, including 137,000 to 176,000 tonnes of copper and 263,000 to 319,000 ounces of gold as the company anticipates stronger production in the second half of 2024 in accordance with the mine production profile. The company expects 2024 consolidated copper production to be below the midpoint of the guidance range, while 2024 consolidated gold production is expected to be above the midpoint of the guidance range.
|
TPC | Hot Stocks06:03 EDT Tutor Perini unit awarded $35.5M boiler plant project in Manhattan - Tutor Perini announced that its subsidiary, WDF, Inc., has been awarded a project valued at approximately $35.5M by the New York City Housing Authority to construct a new boiler plant at George Washington Carver Houses, a 13-building public housing development in Manhattan. The scope of work includes replacement of the existing boiler plant with new boilers, domestic hot water heaters and sump pumps serving the facility. Work is expected to begin this month with substantial completion anticipated in January 2027. The contract value was added to the company's backlog in the second quarter of 2024.
|
LTTS SHEL | Hot Stocks05:38 EDT L&T Technology Services, Shell sign new framework agreement - L&T Technology Services (LTTS) announced that it has signed a long-term framework agreement with Shell (SHEL). The multi-year framework agreement will see LTTS providing Integrated Engineering and Procurement Services along with Digital Engineering Services, Data Governance for Capital Projects and Digital Project Management Consultancy for Shell's global assets as necessary.
|
PHG | Hot Stocks05:18 EDT Philips, Isala hospital renew long-term strategic partnership - Philips and Isala hospital have renewed their long-term strategic partnership. This collaboration aims to ensure healthcare remains accessible, available, and affordable by leveraging Philips' advanced technology, data analytics, and AI. Focusing on the radiology and cardiology departments, it follows a collaboration that began in 2012. The new agreement will last for five years, with an option to extend for another five years. Isala will utilize Philips' technology to optimize processes and deliver more patient-centered care. Together, they will integrate new technologies into hospital operations and continuously improve products based on feedback. Isala will replace medical systems, such as MRI and CT scanners, through a multi-year plan. Continuous updates will keep systems up to date, extending their lifespan. Philips will provide essential medical imaging systems and support services to improve clinical adoption and streamline processes.
|